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Abstract 
 
The development of the nervous system is a complex task that involves precise connections 
between billions of neurons.  This is achieved, at least in part, by the overproduction of neurons 
and the survival of a select few that compete for limited survival and growth promoting factors, 
such as neurotrophic factors.  The neurotrophin brain-derived neurotrophin factor (BDNF) has 
been shown to play an important role in proliferation and differentiation of cortical neuronal 
precursors (Bartkowska et al 2007).  Moreover, BDNF induces binding of the transcription factor 
CREB to gene promoters in a nitric oxide (NO)-dependent manner (Riccio et al 2006).  NO 
positively  regulates  a  large  number  of  transcription  factors  and  genes  in the  nervous  system 
(Hemish et al 2003; Dhakshinamoorthy et al 2007).  I have demonstrated that NO achieves this 
broad level of gene regulation by influencing chromatin remodelling.  My data also show that NO 
accumulates within the nucleus of cortical neurons upon BDNF stimulation, thereby inducing S-
nitrosylation  of  a  wide  array  of  nuclear  proteins.    S-nitrosylation  of  histone  deacetylase  2 
(HDAC2) decreases its affinity for chromatin, leading to increased histone acetylation levels.  
This NO-dependent regulation of HDAC2 promotes changes in endogenous gene expression and 
affects the dendritic length of cortical neurons.   3 
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Chapter 1  Introduction 
 
The  mature  mammalian  brain  coordinates  an  overwhelming  diversity  of  functions, 
including  perception,  motor  coordination,  learning  and  memory.    This  is  reflected  in  the 
complexity  of  its  development,  which  is  incomparable  to  any  other  biological  organ.    The 
development of the nervous system requires the generation of a large number of neuronal cell 
types followed by migration of neuronal precursors to target destinations, axonal elongation and 
the establishment of contacts with specific target cells.  The major contribution to the functional 
complexity  exhibited  by  the  mammalian  brain  is  attributed  to  the  recent  evolution  of  the 
neocortex.  The rapid expansion of the neocortex in humans is fundamental for our ability for 
abstract thought and consciousness.  Deciphering the molecular mechanisms that underlie cortical 
development  will  provide  novel  insights  into  biological  processes  such  as  cell  survival, 
proliferation, cell fate determination, cell migration and differentiation. 
 
1.1 Transcriptional signalling during cortical development 
 
The  predominant  cell  type  generated  during  mammalian  cortical  development  is  the 
pyramidal  projection  neuron,  which  comprises  up  to  85%  of  the  total  neuronal  population 
(Hevner 2006). Pyramidal neurons make long excitatory connections to both cortical and sub-
cortical nuclei and uses glutamate as a neurotransmitter.  The remaining cortical neurons are 
interneurons that release the inhibitory neurotransmitter, γ-aminobutyric acid (GABA).  They 
have a more diverse morphology and make short “local” inhibitory connections (Butt et al 2007).  
Interneurons are generated within the medial ganglionic eminence of the ventral telencephalon   8 
and migrate tangentially into the cortex.  In contrast, pyramidal neurons are generated from radial 
glial cells located along the lateral ventricular surface of the dorsal telencephalon, called the 
ventricular zone (VZ) (Gupta et al 2007).  Progenitor cells migrate radially from the VZ into the 
subventricular  zone  (SVZ)  and  intermediate  zone  (IZ)  were  they  form  pyramidal  precursor 
neurons.    These  precursor  cells  later  migrate  into  the  cortical  plate  where  they  terminally 
differentiate and form the six-layered structure of the adult neocortex (Gupta et al 2007).  The 
origin  of  interneurons  and  pyramidal  neurons  within  distinct  telencephalic  regions  allows 
differential  exposure  to  extracellular  cues.    Spatially  segregated  differentiation  determines 
distinct  molecular,  migrational  and  morphological  properties  of  interneurons  and  pyramidal 
neurons, providing cell diversity within the cortex. 
 
Neuronal  progenitors  within  the  VZ  initially  express  transcription  factors  that  regulate 
transcription  of  genes  necessary  for  establishing  regional  boundaries  between  the  dorsal 
telencephalon and sub-cortical regions, such as  the ventral telencephalon.  Regionalization is 
maintained in part by the expression of transcription factors belonging to the homeodomain, the 
paired  and  homeobox,  the  nuclear  receptor,  and  the  basic  helix-loop-helix  (bHLH)  families 
(Bertrand et al 2002; Schuurmans and Guillemot 2002).  Generation of pyramidal neurons from 
progenitor cells involves two conflicting processes, proliferation and differentiation, with the 
bHLH transcription factors being the foremost regulators.  For example, the Id and Hes families 
maintain proliferation while suppressing neuronal development, as opposed to neurogenin (Ngn) 
1 and Ngn2, which promote neuronal commitment and exit from the cell cycle (Ross et al 2003). 
   9 
Migration  of  pyramidal  neurons  to  distinct  layers  within  the  cortex  is  associated  with 
expression of layer-specific transcription factors and has been comprehensively characterised.  
For  example,  the  paired  and  homeobox  transcription  factor,  Pax6,  is  a  specific  marker  of 
progenitor cells in the VZ and is absent from early neuronal precursor cells of the SVZ.  Upon 
commitment  of  progenitor  cells  to  a  neuronal  cell  fate,  they  begin  to  express  the  T-domain 
transcription factor Tbr2.  As these newborn neurons migrate out of the SVZ into the IZ, they 
downregulate Tbr2 and induce the expression of Tbr1.  The expression pattern of transcription 
factors from Pax6→Tbr2→Tbr1 follows the developmental sequence of radial glial→neuronal 
precursor→postmitotic  pyramidal  neuron  (Hevner  2006).  Stringent  temporal  and  spatial 
expression  of  transcription  factors  is  important  for  coordinating  cortical  development  and 
provides a useful tool for marking progression of neuronal precursor development. 
 
Similarly, specification of neuronal subtypes is determined by the pattern of transcription 
factors that are induced during development.  For example, differentiation of interneurons is 
dependent  on  the  expression  of  the  bHLH  transcription  factor,  Mammalian  achaete  scute 
homolog 1 and 2 (Mash1), whereas Ngn2 is necessary for the development of pyramidal neurons.  
Expression of Mash1 induces transcription factors, Dlx1 and Dlx2, which subsequently activate 
genes associated with interneuron specification and migration (Cobos et al 2005; Kitamura et al 
2002).  These include expression of glutamic acid decarboxylase (GAD67), an enzyme essential 
for GABA synthesis (Anderson et al 1999).   
 
Expression of genes controlled by specific transcription factors is essential for switching 
from  proliferation  of  progenitor  cells  to  the  terminal  differentiation  of  neuronal  and  glial   10 
populations and for regulating many other neurodevelopmental processes including the onset of 
differentiation, cell migration, programmed cell death and cell size.  Coordination of the temporal 
and  spatial  expression  of  specific  transcription  factors  during  development  is  regulated  by 
intrinsic and extrinsic factors, including the pro-survival and growth-promoting neurotrophins 
(Ooi and Wood 2008). 
 
1.2 Role of neurotrophins in neuronal development 
 
Nerve  Growth  Factor  (NGF)  is  the  prototypic  neurotrophin  and  was  identified  half  a 
century ago by Victor Hamburger and Rita Levi-Montalcini (Levi-Montalcini and Booker 1960).  
It  was  originally  described  as  a  growth  factor  that  promotes  survival  and  differentiation  of 
sympathetic and sensory neurons.  This neurotrophin hypothesis is a widely accepted model for 
the development of the peripheral nervous system (PNS).  Neurons are initially generated in great 
excess and then reduced to a select few during a critical window in development.  This selection 
process is achieved through competition for prosurvival and growth-promoting factors released 
from peripheral target tissues, which include neurotrophins (Cowan 2001; Huang and Reichardt 
2001). 
 
The initial discovery of NGF was closely followed by the identification of three additional 
mammalian  neurotrophins,  BDNF,  neurotrophin-3  (NT-3)  and  neurotrophin-4/5  (NT-4/5).  
Neurotrophins normally function as homodimers however, BDNF is able to form heteromeric 
associations with NT-3 and NT-4/5 (Strohmaier et al 1996).  All four neurotrophins bind with 
low-affinity to p75NTR, a distant member of the tumour necrosis factor receptor family.  It was   11 
later discovered that neurotrophins bind with much higher affinity to tropomyosin-related kinases 
(Trk), which belong to the tyrosine kinase receptor family.  Each of the neurotrophins exhibits a 
preferential binding for one of the Trk receptors.  NGF binds with high-affinity to TrkA, BDNF 
and NT-4/5 to TrkB, and NT-3 to TrkC, although NT3 can also bind TrkA and TrkB receptors 
with a lower affinity (Fig. 1.1) (Reichardt and Huang 2001). 
 
 
Figure 1.1 Neurotrophins and their receptors.  All four neurotrophins bind with low-affinity to p75NTR.  
Each neurotrophin exhibits a preferential binding for one of the Trk receptors.  NGF binds with high-affinity to 
TrkA, BDNF and NT4/5 to TrkB, and NT-3 to TrkC.  NT-3 also binds TrkA and TrkB receptors with a lower 
affinity. 
 
NGF and NT-3 are essential survival factors for peripheral sensory and sympathetic ganglia 
in vivo (Huang and Reichardt 2001; Blum and Konnerth 2005).  Different neuronal populations   12 
within the same ganglia can be distinguished by distinct morphological and functional properties, 
and express receptors for specific neurotrophins.  A striking example is demonstrated in dorsal 
root  ganglia  (DRG),  which  contain  a  mixed  neuronal  precursor  population  that  can  be 
distinguished according to the Trk receptor expressed.  DRG precursors expressing TrkA respond 
to  NGF  and  form  nociceptive  neurons,  whereas  TrkC-positive  cells  differentiate  into 
proprioceptive neurons in response to NT-3 stimulation (Crowley et al 1994; Smeyne et al 1994; 
Farinas et al 1996).  It is now clear that neurotrophins play additional roles in the development of 
the PNS besides promoting cell survival, such as axon growth, dendritic development and soma 
hypertrophy (Purves et al 1988; Snider 1988; Fagan et al 1996; Patel et al 2000; Ye et al 2003). 
 
Neurotrophins also play a key role in the development of the CNS, including cell survival, 
proliferation, differentiation, synaptic transmission and plasticity (Huang and Reichardt 2003; 
Blum & Konnerth 2005).  During the development of the cortex, precursor cells in the SVZ 
express the neurotrophins BDNF and NT3, as well as their high affinity receptors TrkB and TrkC 
(Maisonpierre et al 1990) (Ernfors et al 1992) (Fukumitsu et al 1998).  Neurotrophin-mediated 
TrkB  and  TrkC  signalling  is  essential  for  regulating  proliferation  and  differentiation  of 
embryonic  cortical  precursors.    NT3,  for  example,  regulates  cell  cycle  exit  and  neuronal 
differentiation of cortical progenitors cells (Ghosh and Greenberg 1995).  Cortical precursor cells 
also synthesize and secrete BDNF that promotes survival and differentiation in an autocrine and 
paracrine fashion both in vitro (Barnabe-Heider and Miller 2003) and in vivo (Bartkowska et al 
2007).  Administration of BDNF into the lateral ventricles of embryonic mice enhances the radial 
migration of cortical neurons (Ohmiya et al 2002; Fukumitsu et al 2006).  BDNF has been shown 
to facilitate survival and neurogenesis through activation of the phosphatidylinositol-3-kinase   13 
(PI3K)  and  MEK  pathways  (Barnabe-Heider  and  Miller  2003),  and  to  activate  pro-neuronal 
bHLH  transcription  factors,  such  as  Mash1  and  Math1  (Ito  et  al  2003).    Cell-type  specific 
deletion of BDNF high affinity receptor in transgenic mice has shown that deletion of TrkB 
within cortical pyramidal neurons during development causes altered neuronal arborisation and 
compression of the cortex (Xu et al 2000).  Later phenotypes of TrkB deletion include the loss of 
suppressed,  cAMP-inducible  POU  (SCIP)-expressing  neurons  in  somatosensory  and  visual 
cortices  (Xu  et  al  2000).    These  data  indicates  that  BDNF/TrkB  signalling  is  necessary  for 
supporting the survival and differentiation of CNS neurons. 
 
1.2.1 Neurotrophin signalling 
 
Tyrosine  kinase  signalling  mediated  through  activation  of  Trk  receptors  promotes 
developmental processes associated with neurotrophin stimulation, including cell survival and 
differentiation.  Ectopic expression of Trk receptors in embryonic neurons is associated with the 
acquisition of NGF-mediated survival response (Allsopp et al 1994; Barrett and Bartlett 1994).  
Neurotrophin-mediated signalling requires Trk receptor dimerization and auto-phosphorylation of 
three conserved cytoplasmic tyrosine residues.  These are located within the autoregulatory loop 
of the kinase domain and are necessary for tyrosine kinase activity.  Seven additional conserved 
tyrosine residues on Trk receptors can be phosphorylated and act as docking sites for adaptor 
proteins  and  kinases  containing  phosphotyrosine-binding  (PTB)  or  src-homology-2  (SH-2) 
motifs.  Many of these proteins are additional substrates for the Trk receptor tyrosine kinase.  
Numerous intracellular signalling pathways are initiated upon Trk receptor activation, including   14 
Ras/ERK (extra-cellular signal-regulated kinase) protein kinase pathway, the PI3K/Akt pathway 
and the phospholipase C (PLC)-γ1 pathway (Fig. 1.2) (Huang and Reichardt 2001).   
 
 
Figure  1.2  Trk  receptor  activation  and  downstream  signalling.    Trk  receptors  form  dimers  upon 
neurotrophin  binding,  which  leads  to  auto-phosphorylation  of  an  intracellular  tyrosine  kinase  domain.  
Phosphorylated  tyrosine  residues  on  Trk  receptors  act  as  docking  sites  for  adaptor  proteins  and  kinases,  which 
activate several intracellular signalling pathways including PI3K/Akt, Ras/MAP kinase and PLC-γ1 pathways.  Trk-
mediated  signalling  is  important  for  neuronal  functions,  including  survival,  growth,  differentiation,  synaptic 
transmission and memory.  Taken from Blum and Konnerth, 2005. 
   15 
Ras activation and recruitment to Trk receptors following binding to neurotrophins requires 
the association of adapter proteins, including Shc and Grb-2 and activation of the Ras exchange 
factor, SOS.  Downstream Ras signalling mediates transient activation of several kinase cascades, 
including the Extracellular signal-Regulated Kinase (ERK), Mitogen-Activated Protein Kinase 
(MAPK) and PI3K (Huang and Reichardt 2001).  Activated MAPK leads to phosphorylation of 
p90 ribosomal S6 kinase (Rsk) and activation of pro-survival pathways (Bonni, 1999).  This 
includes sequestering of proapoptotic BAD and activation of the prosurvival transcription factor, 
cAMP-Regulated Element Binding protein (CREB) (Bonni et al 1999).  Importantly, activation 
of ERK kinase  signalling upon neurotrophin stimulation leads to transformation of a neural-
derived cell line, PC12, into a differentiation-like phenotype (Tanaka et al 1993; Matsuda et al 
1994;  Hempstead  et  al  1994).    These  examples  demonstrate  that  Ras-activated  kinases  are 
important for promoting neuronal survival and differentiation. 
 
PI3K is predominantly activated by Ras; however, PI3K function can also be activated by 
Shc and Grb-2 independently of Ras (Holgado-Madruga et al 1997)(Kaplan and Miller 2000).  
PI3K  leads  to  activation  of  Akt/protein  kinase  B,  and  mediates  survival  of  many  neuronal 
populations  including  cerebellar  granule  cells  and  sympathetic  neurons  (Bonni  et  al  1999; 
Vaillant et al 1999).  Activated Akt controls various proteins involved in cell death, such as BAD, 
IKB,  human  caspase  9  and  glycogen  synthase  kinase  3-β  (Datta  et  al  1999).    For  example, 
phosphorylation  of  IKB  targets  it  for  degradation,  which  prevents  IKB  from  binding  and 
sequestering the transcription factor, NFKB.  Degradation of IKB allows nuclear translocation of 
NFKB and subsequent activation of pro-survival genes (Middleton et al 2000).  Pharmacological   16 
studies have demonstrated that the PI3K pathway is also capable of activating CREB, through 
mechanisms that remain elusive (Lin et al 2000; Perkinton et al 2002). 
 
Many developmental functions regulated by neurotrophins require the activation of Ca
2+-
dependent  pathways.    The  major  route  for  Trk-dependent  elevation  of  intracellular  Ca
2+  is 
mediated by the PLC-γ1 pathway.  PLC-γ1 catalyzes the hydrolysis of phosphatidylinositol-4,5-
bisphosphate (PIP2) to generate inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).  IP3 
induces Ca
2+ release from intracellular stores, leading to activation of Ca
2+-regulated isoforms of 
protein kinase C (PKC) (Corbit et al 1999).  PLC-γ1 signalling further modulates intracellular 
Ca
2+  concentrations  through  the  gating  of  a  Ca
2+-permeable  plasma-membrane  channel.  The 
canonical form of transient receptor potential (TRPC) channel is activated upon BDNF-induced 
synthesis  of  IP3  and  DAG  (Li  et  al  1999;  Clapham  2003;  Amaral  and  Pozzo-Miller  2007).  
BDNF-dependent gating of TRPC channels through PLC-γ1 activation has been associated with 
growth cone development (Li et al 1999; Li et al 2005). 
 
In addition to PKC, elevated intracellular Ca
2+ following neurotrophin stimulation activates 
many different classes of protein kinases.  Interaction of Ca
2+ with its binding protein, calmodulin 
(CaM),  forms  a  complex  that  activates  several  CaM-regulated  kinases  and  phosphatases, 
including the CREB kinases, CaMKI, CaMKII and CaMKIV (Dash et al 1991; Sheng et al 1991; 
West et al 2001).  Certain subtypes of adenylyl cylases are also regulated by Ca
2+, resulting in 
elevated  levels  of  cyclic  adenosine  monophosphate  (cAMP)  and  subsequent  activation  of  an 
additional  CREB  kinase,  cAMP-dependent  protein  kinase  (PKA)  (Gonzalez  et  al  1989).    In   17 
summary,  neurotrophin-induced  activation  of  Trk  signalling  leads  to  activation  of  several 
pathways that converge to regulate pro-survival transcription factors, such as NFKB and CREB. 
 
1.2.2 CREB – a transcriptional target of neurotrophin signalling 
 
One important nuclear target of neurotrophin signalling is the transcription factor CREB 
(Ginty et al 1994; Bonni et al 1995).  NGF stimulation of PC12 cells and sympathetic neurons, 
and  BDNF  stimulation  of  cortical  and  cerebellar  granule  cells  has  been  shown  to  induce 
phosphorylation and activation of CREB (Ginty et al 1994; Riccio et al 1997; Bonni et al 1999). 
CREB-mediated gene expression is necessary and sufficient for the survival and differentiation of 
sympathetic and sensory neurons in vitro and in vivo (Lonze et al 2002; Mantamadiotis et al 
2002; Riccio et al 1999).  In addition to promoting neuronal survival, CREB has been implicated 
in a diverse range of neuronal processes from axonal (Rudolph et al 1998) and dendritic growth 
(Redmond et al 2002) to regulation of circadian rhythms, learning and memory (Lonze and Ginty 
2002). 
 
CREB is a bZIP transcription factor containing a C-terminal basic domain that mediates 
DNA  binding  to  cAMP  Response  Elements  (CREs).    CREB  activation  is  mediated  by 
phosphorylation  of  Ser133  located  within  its  kinase  inducible  domain.    Phosphorylation  of 
Ser133 results in binding of CREB to the transcriptional co-activator, CREB Binding Protein 
(CBP).  CBP has an endogenous histone acetyltransferase activity and catalyses acetylation of 
histone proteins.  Stimulus-induced CREB phosphorylation recruits CBP to CRE-containing gene   18 
promoters,  resulting  in  hyperacetylation  of  histones  and  local  chromatin  unravelling.    A 
relaxation of chromatin structure permits binding of transcription machinery and gene activation. 
 
CREB  regulates  hundreds  of  genes  that  are  diverse  in  function  including 
neurotransmission,  cellular  metabolism,  transcription  and  signal  transduction  (Mayr  and 
Montminy 2001).  Despite the fact that all CREB-regulated genes share a similar CRE element, 
their expression profile varies widely, depending on the cell type and the extracellular stimuli.  
This is suggestive that CREB regulation requires a more complex mechanism than a simple on-
off switch, as described above.  The Chromatin ImmunoPrecipitation (ChIP) technique is a highly 
sensitive assay for detecting DNA-protein complexes and it has been used to demonstrate that 
CREB is not constitutively bound to many transcriptionally inactive gene promoters (Riccio et al 
2006).    Neurotrophin-dependent  gene  expression  in  cortical  neurons  requires  both  CREB 
phosphorylation  and  CREB  binding  to  CRE-containing  gene  promoters.    Notably,  these  two 
processes occur independently through distinct signalling pathways and are both necessary for 
CREB-regulated gene activation (Riccio et al 2006).  Regulation of CREB binding to promoters 
of specific genes provides a mechanism for differential activation of CREB-regulated genes in 
specific cell-types.  It is well established that transcription factor binding to gene promoters is 
dependent on local changes of chromatin structure.  Epigenetic modifications, such as histone 
acetylation, allow stable remodelling of chromatin that favours gene activation or repression.  
Maintenance  of  specific  genes  as  either  repressive  or  poised  for  activation  may  provide  an 
intrinsic  mechanism  that  dictates  which  CREB-regulated  genes  are  activated  in  response  to 
extrinsic stimuli. 
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1.3 Epigenetic events and neuronal development   
 
During cortical development, neurons are the first cell type generated and are produced in a 
regulated sequential pattern that results in an inside out layering of the cortex.  This initial peak 
of neurogenesis is followed by the generation of astrocytes and later oligodendrocytes.  These 
diverse cortical cell types arise from the same population of radial glial progenitor cells, which is 
determined  by  the  temporal  expression  of  specific  transcription  factors.    Many  of  the 
transcription factors required for neuronal differentiation have been identified and characterised.  
However, the binding of transcription factors to target genes is dependent on additional factors 
other than the DNA primary sequence.  Epigenetic modification of DNA and histone proteins 
changes the overall structure of chromatin, which regulates the access of transcription factors to 
gene promoters and drives transcription. 
  
Adrian Bird has recently proposed a revised definition of epigenetics as “the structural 
adaptation of chromosomal regions so as to register, signal or perpetuate altered activity states” 
(Bird  2007).    Epigenetic  modification  of  chromatin  is  an  intrinsic  mechanism  that  allows 
regulation  of  gene  transcription,  DNA  repair,  replication,  and  chromosome  condensation 
(Kouzarides  2007).    DNA  is  packaged  into  chromatin  through  association  with  protein 
complexes called nucleosomes.  A nucleosomal unit comprises 146 base pairs of DNA wrapped 
around  an  octameric  histone  complex  composed  of  one  H3/H4  tetramer  and  two  H2A/H2B 
dimers  (Luger  et  al  1997).    Nucleosomes  are  connected  by  20-60  base  pairs  of  DNA  that 
associate  with  the  linker  histone  H1.    Chromatin  exists  either  as  highly  condensed 
heterochromatin  or  less  compact  euchromatin.    Heterochromatin  is  resistant  to  endonuclease   20 
digestion,  is  late-replicating,  rich  in  repetitive  sequences,  and  transcriptionally  silent.  
Euchromatin  organisation  is  more  dynamic  and  can  change  transiently,  allowing  for  gene 
activation and repression in response to extracellular cues.  Epigenetic regulation of chromatin 
involves  covalent  modification  of  both  DNA  and  the  N-terminal  tail  of  histone  proteins 
(Kouzarides 2007).   
 
1.3.1 DNA modifications 
 
DNA methylation is associated with gene silencing and plays a major role in modulating 
differentiation of neuronal progenitor cells (Allen 2008).  Methylation of CpG nucleotide islands 
is catalysed by two classes of DNA methyl-transferases (DNMT): the ubiquitously expressed 
DNMT1  uses  hemi-methylated  DNA  as  a  template  ensuring  inheritance  of  established 
methylation patterns from parental to daughter DNA strands, whereas DNMT3a and DNMT3b 
catalyse de novo DNA methylation and exhibit a greater degree of differential expression during 
the development of the CNS (Robertson and Wolffe 2000; Goll and Bester 2004).  Dnmt3b for 
example,  is  expressed  earlier  during  development  (E10-14)  in  progenitor  cells  of  the  VZ, 
coinciding with the major period of cortical neurogenesis (Feng et al 2005).  In contrast, Dnmt3a 
expression  persists  postnatally,  indicating  a  role  in  gene  silencing  necessary  for  neuronal 
maturation (Feng et al 2005).  Recruitment of DNMTs for de novo methylation is dependent on 
ATP-dependent remodelling complexes.  DNA methylation can repress gene expression through 
either direct or in-direct mechanisms.  DNA methyl groups situated within the major groove of 
double  helix  DNA  can  directly  disrupt  the  binding  ability  of transcription  factors (Watt  and 
Molloy 1988; Takizawa et al 2001).  Alternatively, DNA methylation sites recruit methyl-CpG-  21 
binding domain (MBD)-containing proteins, such as MeCP2, MBD1 and MBD2.  Methylation-
dependent repression can occur through interaction of MBD proteins with the transcriptional 
machinery or by modifying chromatin structure (Takizawa et al 2001).  For example, MeCP2 has 
a  transcriptional  repression  domain  (TRD)  that  binds  the  transcriptional  corepressor  Sin3A, 
which recruits HDAC activity to nucleosomes (Matijevic et al 2008). 
 
MeCP2-mediated  repression  is  important  for  postnatal  neuronal  maturation  and 
synaptogenesis (Smrt et al 2007).  Disruption of MeCP2 expression results in Rett syndrome, a 
neurodegenerative disorder characterised by a regression of language and motor skills, followed 
by mental retardation the first year after birth (Matijevic et al 2008).  Over-expression of Bdnf in 
MeCP2  mutant  mice  rescues  the  locomotor  deficit,  demonstrating  a  functional  interaction 
between MeCP2 and BNDF in vivo (Chang et al 2006).  MeCP2 regulates the expression of Bdnf 
by selectively binding and repressing the BDNF promoter (Chen et al 2003; Martinowich et al 
2003).  Neuronal activity causes Ca
2+ influx and MeCP2 phosphorylation, which is released from 
the  BDNF  promoter.    BDNF  expression  is  associated  with  neuronal  plasticity,  learning  and 
memory, which may account for certain Rett syndrome phenotypes.  MBD proteins, such as 
MeCP2,  are  all  components  of  chromatin-remodelling  complexes  and  closely  couple  gene 
repression with histone methylation and acetylation (Fuks 2005).   
 
1.3.2 Histone modifications 
 
Histones can undergo a large number of posttranslational covalent modifications at their N-
terminal  tails,  including  acetylation,  methylation,  phosphorylation,  ADP-ribosylation,   22 
sumoylation  and  ubiquitination  (Fig.  1.3)  (Kouzarides  2007).    Histone  acetylation  and 
methylation are currently the most extensively studied epigenetic modifications and will be the 
focus of my literature review. 
 
 
Figure 1.3 Schematic representation of chromatin (top), chromatin fibre (middle) and nucleosome structure 
(lower).  DNA  is depicted  in black  and nucleosome histone cores  as yellow  spheres.  Histone posttranslational 
modifications have been depicted as circles: ADP-ribosylation (ADP, pink), phosphorylation (P, orange), acetylation 
(Ac,  blue),  methylation  (Me,  green),  ubiquitination  (Ub,  purple)  and  sumoylation  (SUMO,  grey).    Histones  are 
acetylated  by  Histone  Acetyltransferases  (HAT,  blue)  and  acetyl  groups  are  removed  by  Histone  Deacetylases 
(HDAC, green).  Taken from Kimura et al, 2005. 
 
1.3.3 Histone methylation 
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Methyl  groups  are  added  to  histone  lysine  and  arginine  residues  by  histone 
methyltransferases (HMT).  In humans and mice, fourteen different HMTs have been identified 
that  generally  exhibit  high  specificity,  often  methylating  a  single  residue  on  specific  histone 
proteins (Bannister and Kouzarides 2005).  Lysine residues can be mono-, di- or tri-methylated 
and arginines can be either mono- or di-methylated (symmetrically or asymmetrically), adding 
another level of complexity (Berger 2007).  The addition of small methyl groups is unlikely to 
change charges on lysine and arginine residues, which suggests that chromatin structure will 
remain unaltered.  Epigenetic regulation of transcription following histone methylation is likely 
to be dependent on recruitment of nuclear proteins via chromo-like binding domains.  Histone 
lysine  demethylases  (HDMT)  have  recently  been  discovered  and  display  the  ability  to 
specifically interact with mono-, di-, or tri-methylated lysine residues (Shi et al 2004; Metzger et 
al 2005; Tsukada et al 2006).  So far, no ariginine demethylases have been identified. 
 
During early stages of development, global chromatin environments are established, with 
large regions that remain silent (heterochromatin) whereas other regions become transcriptionally 
active (euchromatin).  Methylation of H3K4 and H3K9 is present at the boundary of euchromatin 
with heterochromatin and is important for dictating and preserving the two types of chromatin 
domains (Kouzarides 2007).  Heterochromatin regions of DNA are associated with high levels of 
methylation at specific histone lysine residues, H3K9, H3K27 and H4K20 (Barski et al 2007).  
Euchromatin has a dynamic biological output compared to heterochromatin and therefore a more 
flexible modification pattern to reflect this.  Transcriptionally active euchromatin is associated 
with trimethylated histone H3K4 and H3K36, conversely methylation of these residues is low in 
silent regions of euchromatin (Barski et al 2007).  The chromo-domain proteins that recognise   24 
methylated  histone  lysines  dictate  the  mechanistic  and  functional  consequence  of  these 
modifications.    H3K9  methylation  recruits  the  repressive  protein  Heterochromatin  Protein  1 
(HP1), which provides a platform for the binding of DNA methyltranserases (Lehnertz et al 2003; 
Fuks et al 2003).  This event results in DNA methylation near chromatin regions containing 
H3K9  methylation  and  the  subsequent  recruitment  of  MBD  proteins  associated  with  gene 
repression (Fuks 2005).  In contrast, the transcriptional activator Chromo-ATPase/Helicase-DNA 
binding Domain 1 (CHD1), binds to methylated H3K4, which recruits chromatin remodelling 
complexes  associated  with  gene  activation  (Pray-Grant  et  al  2005).    These  two  examples 
demonstrate  that  the  function  of  methylated  histone  lysines  is  dependent  on  recruitment  of 
specific activating or repressing methyl-binding proteins. 
 
1.3.4 Histone acetylation 
 
Histone acetylation, the most widely studied epigenetic modification, involves the cleavage 
of  acetyl  groups  from  acetyl-coenzyme  A  and  its  addition  to  the  ε-NH
+  of  lysine  residues.  
Acetylation of histones is catalysed by histone acetyl-transferases (HATs), which are divided into 
three  main  families,  CBP/p300,  MYST  and  GNAT  and  exhibit  virtually  no  preference  for 
specific lysine residues (Roth et al 2001; Carrozza et al 2003).  The majority of acetylated lysine 
residues  are  located  within  the  more  accessible  N-terminal  tail  of  histones.    Acetylation  of 
histones has a direct influence on chromatin structure as it reduces the positive charge on lysine 
residues, which decreases the affinity of histones for negatively charged DNA.  This allows a 
localised  ‘unravelling’  of  chromatin,  making  it  more  accessible  for  binding  of  further  co-
activators and basal transcription machinery.  Histone acetylation also provides a platform for   25 
chromatin  remodelling  proteins  that  contain  bromo-domains,  such  as  the  SWI/SNF  complex 
(Kouzarides  2007).    The  assembly  of  these  large  multiprotein  complexes  is  important  for 
initiation of transcription, DNA replication and repair and further histone modifications. 
 
Acetylation of histone H3 at lysine residues 9 and 14 (AcH3K9/K14) and histone H4 at 
lysine residues 5, 8, 12, and 16 (AcH4) has been mapped on transcriptional initiation sites of 
active genes (Pokholok et al 2005).  Hyperacetylation of histone H3 and H4 correlate positively 
with DNA binding of various HATs and DNA polymerase II (Pol II).  It should be considered 
that different histone modifications are not mutually exclusive, for example tri-methylation of 
histone H3K4 exhibits a similar genomic profile as described for AcH3K9/K14 (Guenther et al 
2007).  However, tri-methylation of histone H3K36 is associated with transcriptional elongation, 
is enriched within the coding regions of active genes and is almost absent at the transcriptional 
initiation site of active genes (Guenther et al 2007). 
 
The removal of acetyl groups is catalysed by histone deacetylase proteins (HDACs) and is 
associated with chromatin condensing and transcriptional repression.  There are four classes of 
HDACs, class I (HDACs 1-3 and 8), class II (HDACs 4-7, 9 and 10) and class IV (HDAC 11) 
that  are  all  zinc-dependent,  whereas  class  III  (SIRT  1-7)  require  the  cofactor,  NAD
+ 
(Thiagalingam et al 2003; Yang and Gregoire 2005).  Class I HDACs show high homology to 
yeast  Reduced  potassium  dependency-3  (Rpd3)  and  with  the  exception  of  HDAC3,  are 
ubiquitously expressed and principally localised in the nucleus.  Class II HDACs are homologous 
to yeast Histone deacetylase-1 (Hda-1).  They exhibit a tissue-specific expression and shuttle 
between the nucleus and cytoplasm (as does HDAC3).  HDAC11, the sole member of class IV   26 
HDACs, shows an intermediate homology to both Rpd3 and Hda1.  Sirtuins (class III HDACs), 
are  homologous  to  silent  information  regulator-2  (sir2)  and  are  evolutionarily  distinct  from 
classes I, II and IV HDACs. 
 
1.3.5 Epigenetic control of neurogenesis 
 
The  expression  of  neural  genes  during  development  requires  the  turnover  of  large 
transcriptional complexes that often contain HATs, HDACs, HMTs and HDMTs (Allen 2008).  
During  the  early  stages  of  neuronal  development,  progenitor  cells  are  maintained  in  a 
proliferative  state  through  expression  of  Notch  effectors.    These  include  inhibitory  bHLH 
transcription factors, such as Hes1, that act in concert with co-repressive complexes to inhibit 
neurogenic bHLH genes, such as Ascl1 (Cau et al 2000).  The repressive activity of Hes1 is 
mediated through the recruitment of Sin3A/HDAC complexes that results in localised histone 
hypoacetylation  and  gene  silencing  (Nuthall  et  al  2004).    Exposure  of  progenitor  cells  to 
neurogenic stimuli leads to ADP-ribosylation of the Hes1 complex, which results in dissociation 
of Sin3A/HDAC, recruitment of HATs and hyperacetylation of local histone proteins (Ju et al, 
2004).  The switch of Hes1 from a transcriptional repressor to an activator is dependent on the 
presence of HDACs and HATs within the complex.  Thus, chromatin remodelling is essential for 
transcriptional regulation of neural genes. 
 
Differentiation of progenitor cells into a neuronal phenotype is further regulated by the 
nuclear receptor co-repressor (N-CoR).  Repressive complexes  containing N-CoR  silence the 
gene promoters of down-stream effectors of Notch signalling through the recruitment of HDAC3   27 
(Kao et al 1998). The absence of N-CoR in cortical progenitors prevents FGF-dependent self-
renewal of neuronal progenitors and promotes their differentiation into astrocytes (Hermanson et 
al 2002).  Ciliary neurotrophic factor (CNTF) triggers glial differentiation and leads to Akt1 
kinase-dependent  phosphorylation  of  N-CoR  and  subsequent  relocalization  to  the  cytoplasm 
(Hermanson  et  al  2002).    These  data  imply  that  N-CoR/HDAC3  complexes  play  important 
functions in regulating the differentiation of early-stage progenitor cells specifically by repressing 
gliogenic over neurogenic genes. 
 
Many neuronal genes have a conserved motif called the Repressor Element 1 (RE1), that 
upon  methylation  binds  the  zinc-finger  transcriptional  repressor  RE1  silencing  transcription 
factor  (REST)  (Chong  et  al  1995;  Schoenherr  and  Anderson  1995).    REST  recruits 
Sin3A/HDAC, as well as repressive cofactors CoREST and MeCP2 to sites of gene repression.  
CoREST is a co-repressor that mediates long-term gene silencing by recruitment of HDACs, 
H3K9  histone  methyltransferases  and  the  H3K4  demethylase  LSD1.    REST  silences  many 
neuron-specific  genes  in  non-neuronal  cells,  including  those  encoding  ion  channels, 
neurotransmitter receptors, synaptic vesicle proteins and adhesion proteins (Johnson et al 2007).  
Regulation of REST allows a tight regulation of neuronal development, and later, the plasticity of 
mature neurons (Ballas and Mandel 2005).  A high level of REST in neuronal embryonic stem 
cells  prevents  their  exit  from  the  cell  cycle  and  blocks  premature  neuronal  differentiation.  
Posttranslational downregulation of REST protein allows the activation of selected genes, which 
leads to the developmental progression of progenitor cells to neuronal precursors.  As neuronal 
development proceeds, the Rest gene itself is transcriptional repressed to allow precursor cells to 
differentiate into mature neurons.  The absence of the REST/HDAC/Sin3A/CoREST repressive   28 
complex from gene promoters allows the expression of neuronal terminal differentiation genes 
(Schoenherr  et  al  1996).    However,  the  transcription  of  certain  genes,  including  Bdnf  and 
calbindin,  remains  low  due  to  the  binding  of  CoREST  and  MeCP2  complexes  at  additional 
methylation  sites  (Ballas  et  al  2005).    Neuronal  depolarisation  results  in  phosphorylation  of 
MeCP2 and initiation of Bdnf transcription.  Regulation of MeCP2 repressive complexes binding 
to  neural  gene  promoters  in  response  to  neuronal  activity  provides  a  platform  for  synaptic 
plasticity in mature neurons (Ballas and Mandel 2005). 
 
1.3.6 Regulation of HDAC functions 
 
The function of HDAC proteins can be classified into two areas, the enzymatic deacetylase 
activity of the protein and the functional repressive activity of the protein.  HDACs exist as part 
of large repressive complexes where they play a key role for the recruitment of other corepressor 
proteins.  Binding of these repressors to chromatin is often sufficient for transcriptional inhibition 
in the absence of deacetylase activity (Yang and Seto 2008).  Moreover, HDAC functions are 
also  regulated  by  post-translational  modifications  (phosphorylation,  ubiquitination  and 
sumoylation), subcellular localisation, intracellular protein levels and proteolytic cleavage. 
 
1.3.7 HDAC co-repressors 
 
With  the  exception  of  yeast  HOS3  and  mammalian  HDAC8,  purified  HDACs  are 
enzymatically inactive, as they require assembly into large multi-subunit complexes in order to 
function (Carmen et al 1999; Hu et al 2000; Lee et al 2004).  Additionally, HDAC proteins do not   29 
exhibit target selectivity, as they deacetylate both histone and non-histone substrates and do not 
directly bind DNA (Sengupta and Seto 2004).  Therefore, HDAC repressor function depends on 
interaction with specific corepressors that target them to specific chromosomal loci and regulate 
their enzymatic activity.  HDACs are regulated by multiple signalling pathways and can associate 
with numerous different repressive complexes. 
 
HDAC1  and  HDAC2  exist  in  three  distinct  native  complexes,  the  Sin3A,  NuRD  and 
CoREST  complexes.    These  HDAC-containing  complexes  comprise  similar  core  proteins, 
notably HDAC1, HDAC2, RbAp46 ad RbAp48, with the addition of unique polypeptides that 
make up the native holo-complex (Sengupta and Seto 2004).  Purified HDAC core complexes 
exhibit  limited  deacetylase  activity  that  can  be  restored  through  the  addition  of  specific 
corepressors,  such  as  MTA2  (Zhang  et  al  1999).    The  best  example  of  an  HDAC  activity 
regulated by protein-protein interaction is provided by the association of HDAC3 with Silencing 
Mediator of Retinoid and Thyroid receptor (SMRT) and N-CoR (Wen et al 2000; Guenther et al 
2001; Zhang et al 2002).  The deacetylase activity of HDAC3 is significantly enhanced following 
SMRT/NCoR binding and is therefore regulated by SMRT/NCoR nuclear levels.  
 
The  majority  of  corepressors  that  enhance  class  I  HDAC  enzymatic  activity  contain  a 
SANT domain (Sengupta and Seto 2004).  These motifs are putative DNA binding domains and 
target HDAC complexes to chromatin.  Interestingly, deletion of SANT domains demonstrated 
that they are also important regulators of HDAC activity (Yu et al 2003).  These data demonstrate 
a key role of protein-protein interaction in regulating HDAC repressive function by modulating 
both its localisation and enzymatic activity.   30 
 
1.3.8 HDAC posttranslational modification 
 
In addition to binding with specific corepressors, HDACs are regulated by posttranslational 
modifications such as phosphorylation.  HDAC1 and HDAC2  contain two C-terminal casein 
kinase-2  (CK2)  phosphorylation  consensus  domains,  whereas  HDAC3  has  one.    Serine 
phosphorylation  of  HDAC1-3  increases  deacetylase  activity,  possibly  through  changing  the 
protein conformation to an enzymatically active form (Pflum et al 2001; Tsai and Seto et al 
2002).    Importantly,  HDAC  mutants  that  can  no  longer  be  phosphorylated  exhibit  impaired 
association with the corepressors RbAp48, MTA-2, Sin3A and CoREST (Pflum et al 2001; Tsai 
and Seto et al 2002).  HDAC phosphorylation may increase the affinity of HDAC binding with 
corepressors, which subsequently enhances its deacetylase activity.  In contrast, HDAC8 does not 
have a CK2 consensus domain but is phosphorylated by PKA in vitro and in vivo (Lee et al 
2004).    HDAC8  is  phosphorylated  at  a  non-conserved  serine  residue,  which  decreases  its 
deacetylase activity (Lee et al 2004).  Class II HDACs may also be phosphorylated however, 
there are conflicting evidences supporting either calcium/calmodulin-dependent kinase (CaMK) 
or  Extracellular  signal-Regulated  Kinases  1  and  2  (ERK1/2)  as  potential  HDAC  kinases 
(McKinsey et al 2000; Zhou et al 2000).  Interestingly, phosphorylation of class II HDACs does 
not affect their catalytic activity, instead it affects their subcellular localisation. 
 
HDACs are also regulated by a post-translational modification called sumoylation.  The 
addition of small ubiquitin-related modifier 1 (SUMO-1) to HDAC1 increases its deacetylase 
activity  independently  of  corepressor  binding  (David  et  al  2002).    Sumoylation  of  class  II   31 
HDACs, including HDAC4 and HDAC6 is dependent on interactions with nuclear pore complex 
proteins,  such  as  RanBP2,  and  is  therefore  associated  with  HDAC  nuclear  localisation  and 
increased  transcriptional  repression  (Kirsh  et  al  2002).    In  summary,  post-translational 
modification of class I HDACs predominantly affects deacetylase activity, whereas modification 
of class II HDACs affects mostly their subcellular localisation. 
 
1.3.9 HDAC subcellular localisation 
 
Class I HDACs, with the exception of HDAC3, are nuclear proteins and therefore their 
localisation  is  not  regulated.    Class  II  HDACs  shuttle  in  and  out  of  the  nucleus  and  are 
sequestered within the cytoplasm upon binding to 14-3-3.  Association of HDACs with 14-3-3 is 
dependent  on  HDAC  phosphorylation,  which  leads  to  HDAC  localization  in  the  cytoplasm.  
Binding of 14-3-3 to class II HDACs occludes the nuclear localisation signal and disrupts their 
association with importin-α.  The change in subcellular localisation of class II HDACs is often 
regulated by extracellular stimuli.  In the hippocampus, for example, nuclear export of HDAC4 is 
induced by spontaneous electrical activity, whereas HDAC5 export is induced by Ca
2+ influx 
following activation of N-methyl-D-aspartate receptors (NMDARs). 
 
1.3.10 HDAC protein levels 
 
Targeting  components  of  HDAC  complexes  to  proteosomal  degradation  provides  a 
mechanism to alleviate HDAC repression and allow gene activation.  HDAC1/Sin3A is targeted 
for proteosome-mediated degradation during preadipocyte differentiation (Wiper-Bergeron et al   32 
2003).  N-Cor, a key component of HDAC3 repressive complexes, is targeted for degradation by 
Siah1 in a cell-type specific manner (Zhang et al 1998).  Since N-CoR greatly enhances HDAC3 
activity, reducing the availability of N-CoR will inhibit HDAC3.  HDAC levels may also be 
regulated at the transcriptional level.  Interestingly, HDACs can regulate their own transcription. 
Disruption of HDAC1 in embryonic stem cells, for instance, increases the expression of many 
other class I HDACs (Lagger et al 2002). 
 
Although HDACs have been established as key regulators of transcription, the regulation of 
HDACs themselves has not been fully explored.  It is likely that in addition to the mechanisms 
described here, additional modifications may also influence HDAC activity.  Nuclear shuttling of 
class II HDAC4 and HDAC5, for example, is regulated by Nitric Oxide (NO) signalling (Illi et al 
2008).  Similarly, a recent study indicated that binding of class I HDAC2 to gene promoters is 
regulated by NO-dependent signalling (Riccio et al 2006).  However, the mechanisms by which 
NO influences HDAC functions remain to be elucidated. 
 
1.4 Nitric oxide (NO) 
 
A decade ago, Robert Furchgott, Ferid Murad, and Louis Ignarro were awarded the Nobel 
Prize for demonstrating that a gas is capable of acting as a signalling molecule.  This gas, called 
nitric  oxide  (NO),  is  now  known  to  regulate  many  important  physiological  functions  in  the 
cardio-vascular, immunological and nervous systems. 
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1.4.1 NO synthases 
 
NO is synthesised by the enzyme NO synthase (NOS) through oxidation of the terminal 
guanidine of L-arginine in the presence of oxygen (Fig. 1.4) (Palmer et al 1988).  There are three 
mammalian  NOS  enzymes,  the  Ca
2+-dependent  neuronal  NOS  (nNOS)  and  endothelial  NOS 
(eNOS), and the Ca
2+-independent inducible NOS (iNOS) (Bredt and Snyder 1994).  All three 
isoforms exist as homodimers, with subunits ranging in size from 130 to 160 KDa (Schmidt et al 
1991).  They require a large heterogeneous group of cofactors for their activity, including FAD, 
FMN, heme groups, tetrahydrobiopterin and calmodulin, and two co-substrates NADPH and O2 
(Alderton  et  al  2001).    The  NOS  enzymes  have  a  C-terminal  domain  homologous  with 
cytochrome P450 reductase (CPR) that contains binding sites for NADPH, FAD and FMN (Fig. 
1.4) (Schmidt et al 1993).  
 
The synthesis of NO involves the transfer of five electrons to arginine guanidine nitrogen 
and is catalysed over two independent steps (Fig. 1.4).  First, a two-electron oxidation reaction of 
L-arginine produces a tightly bound N
ω-hydroxyarginine (NHA) intermediate utilizing 1 eq of 
NADPH and 1 eq of O2.  This reaction requires tetrahydrobiopterin and Ca
2+/calmodulin as co-
activators.  The second step involves the production of NO and L-citrulline, the mechanism of 
which is less clear.  Enzymatically, both steps are dependent on all six co-factors and oxygen 
however, only 0.5 eq of NADPH are consumed in the second step, with an additional electron 
possibly provided by NHA (Stuehr and Ikeda 1992). 
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Figure 1.4 Two-phase reaction mechanisms for NO synthesis.  Electron transfer from NADPH to O2 are 
necessary for both phases and require the flavin cofactors, FAD and FMN, and the cytochrome P450 domain.  Phase 
1, L-arginine is hydroxylated to N
ω-hydroyarginine, which requires 1 mol NADPH.  Phase 2, N
ω-hydroxyarginine is 
oxidated to form L-citrulline and NO.  This step consumes 0.5 mol NADPH and is dependent on tetrahydrobiopterin 
(BH4).    NOS  enzymes  are  capable  of  oxidase  activity  in  the  absence  of  L-arginine  (NADPH  oxidase  activity) 
generating hydrogen peroxide (H2O2). Taken from Schmidt et al, 1993. 
 
The co-factor tetrahydrobiopterin substantially increases NO synthesis through a structural 
mechanism that stabilises NOS dimerisation, a prerequisite for its enzymatic activity (Stuehr et al 
1991).  Ca
2+/calmodulin binding to NOS is necessary for electron transfer and oxygen activation, 
but is not required for arginine binding (Matsuda and Iyanagi 1999).  Calcium signalling allows a 
very rapid activation of NOS and induction of NO-dependent events, including neurotransmitter 
release  upon  glutamate  stimulation  of  NMDA  receptors  and  vasodilation  upon  activation  of 
acetylcholine  muscarinic  receptors  in  blood  vessel  endothelial  cells  (Kuriyama  and  Ohkuma 
1995; Elhusseiny and Hamel 2000).  iNOS co-purifies with calmodulin in the absence of Ca
2+,   35 
suggesting that it exists in a native heterotetrameric complex.  iNOS activity is transcriptionally 
regulated  and  its  expression  is  induced  by  extracellular  stimuli  such  as  interferon-γ  and 
lipopolysaccharide signalling (Hecker et al 1999). 
 
Studies in cardiovascular, nervous and musculoskeletal systems have demonstrated that 
phosphorylation of both eNOS and nNOS play a key role in regulating NO production (Mount et 
al 2006).  The two NOS isoforms can be phosphorylated at multiple serine/threonine residues, 
which  in  the  case  of  eNOS  can  either  inhibit  or  enhance  NO  synthesis  (Fulton  et  al  2001).  
Biochemical  studies  have  demonstrated  a  negative  regulation  of  nNOS  following 
phosphorylation by a number of different kinases, including PKC, CaMK and cGMP-dependent 
protein  kinase  (PKG)  (Dinerman  et  al  1994a;  Bredt  et  al  1992;  Hayashi  et  al  1999).    Ca
2+ 
signalling  regulates  NOS  activity  at  two  levels,  initially  by  activating  NOS  through 
Ca
2+/calmodulin  binding  and  later  by  inhibiting  NOS  through  activation  of  CaMKs.  
Additionally, NO can activate soluble guanylyl cyclase (sGC) by binding to the sGC heme group.  
This event increases the levels of cyclic guanosine 3’,5’-monophosphate (cGMP) and activates 
PKG.  Interestingly, NO can directly inhibit NOS activity by binding the N-terminal heme co-
factor, thereby functioning as a potential negative feedback inhibitory mechanism (Rogers and 
Ignarro 1992; Rengasamy and Johns 1993; Assreuy et al 1993). 
 
In addition to regulating its enzymatic activity, phosphorylation of eNOS also determines 
its cellular localisation.  Under basal conditions, eNOS is localised at the plasma membrane of 
endothelial  cells.    Upon  treatment  with  bradykinin,  it  becomes  rapidly  phosphorylated  and 
translocates to soluble fractions (Michel et al 1993).  NOS localisation is important for spatially   36 
restricting  NO  signalling  by  targeting  NOS  enzymes  to  subcellular  compartments,  thereby 
allowing NOS interaction with specific binding partners.  A striking example is provided by the 
localization of NOS isoforms in cardiomyocytes, where eNOS and iNOS are targeted to the 
plasma membrane and sarcoplasmic reticulum respectively, resulting in distinct isoform-specific 
inotropic responses (Petroff et al 2001; Ashley et al 2002; Sears et al 2003).  In neurons, nNOS 
localisation  is  achieved  through  interaction  with  scaffold  proteins,  including  synaptic  density 
proteins (PSD93/95) and carboxy-terminal PDZ ligand of nNOS (CAPON) by interaction with 
PDZ domains (Brenman et al 1996; Jaffrey et al 1998).  PSD93/95 interacts with NMDARs, 
which upon glutamate binding allows Ca
2+ influx, leading to nNOS activation and NO synthesis 
(Kornau et al 1995).  NO directly modifies NMDAR subunits, inhibiting its activity, and thus 
acting  as  an  inhibitory  feedback  loop  (Lipton  et  al  2002).    Conversely,  the  small  G-protein 
Dexras 1 is activated upon NMDAR-induced NO signalling and interacts with nNOS via the 
soluble scaffold protein, CAPON (Fang et al 2000).  Competitive binding of nNOS with CAPON 
and PSD95 is a possible mechanism that regulates nNOS shuttling between synaptic and non-
synaptic sites.  Interaction with CAPON sequesters nNOS from NMDA receptor-mediated Ca
2+ 
influx,  reducing  the  physiologic  and  pathologic  affects  of  synaptic-induced  NO  signalling.  
Localisation of nNOS to specific subcellular compartments will determine its exposure to local 
increases of Ca
2+ and will influence the level of NO signalling. 
 
1.4.2 NO signalling 
 
NO has rapidly emerged as a dynamic regulator of a vast number of proteins.  NO was 
initially demonstrated to bind and regulate the activity of transition metal-containing proteins.  In   37 
addition  to  this,  it  is  now  well  established  that  NO  can  directly  modify  target  proteins  by 
nitrosylation of cysteine (S-nitrosylation) or tyrosine residues (Tyr-nitration).  NO binding to the 
transition metal centre of proteins will either stimulate or inhibit their intrinsic catalytic activity.  
The prototypic example of a transition metal-containing protein regulated by NO is sGC (Murad 
et al 1978; Bohme et al 1978).  Upon binding of NO to the heme moiety of sGC, the heme-iron is 
dislocated, causing a conformational change that results in enzymatic activation.  Activated sGC 
catalyses the synthesis of cGMP, which leads to the activation of several downstream cGMP-
dependent  effectors  (Schmidt  et  al  1993).    cGMP  activates  cGMP-gated  channels, 
phospodiesterases and PKG.  These mediators are important for a number of processes, including 
retinal  rod  response,  olfactory  reception,  steroidogenesis,  renal  and  intestinal  ion  transport, 
platelet aggregation, and cardiac and smooth muscle contractility (Schmidt et al 1993).  It should 
be noted that sGC is also activated independently of NO signalling through other pathways, such 
as CO, •OH and guanylyl cyclase-activating factors (GAFs).  In the nervous sytem, sGC exhibits 
better co-localisation with the GAF protein, heme oxygenase, than with nNOS (Snyder 1992; 
Schmidt  et  al  1992).   Expression  of  sGC  and  nNOS  within  the  cerebellum,  for  example,  is 
mutually  exclusive,  with  nNOS  restricted  to  granule  and  basket  cells  and  sGC  restricted  to 
Purkinje cells (Bredt et al 1990; Nakane et al 1983).  This indicates that NO may not be the 
primary activator of sGC in the nervous system.  However, NO is capable of freely diffusing 
between cells that are in close proximity.  For example, stimulation of parallel fibres leads to NO 
production and diffusion to postsynaptic Purkinje cells where it subsequently activates sGC (Lev-
Ram et al 1995). 
   38 
NO signalling mediates many physiologic and pathologic affects through post-translational 
modification of proteins.  Covalent addition of a NO moiety occurs through direct interaction of 
higher order NO oxide (NOx) species with target tyrosine and cysteine residues, independent of 
additional enzymatic catalysis.  Tyr-nitration is responsible for many of the pathologic effects 
associated with excessive NO signalling in cardiovascular and neuronal diseases or following 
inflammatory  insults  (Ohmori  and  Kanayama  2005;  Peluffo  and  Radi  2007;  Torreilles  et  al 
1999).  Tyrosine nitration involves the oxidation of a Tyr phenolic ring (Tyr•) followed by a 
radical-radical  termination  reaction  with  •NO2,  forming  3-nitrotyrosine  (3-NT)  (Souza  et  al 
2008).  The production of the Tyr• radical is accomplished by the one-electron oxidants, CO3•
–, 
•OH, and •NO2 or by numerous peroxidases.  The generation of 3-NT is ultimately dependent on 
NO which upon reaction with superoxide, forms a powerful intermediate nitrating agent called 
peroxynitrite  (Souza  et  al  2008).    Peroxynitrite  can  homolyze  to  form  the  various  oxidants 
mentioned for 3-NT formation.  Protein tyrosine nitration is a selective process, occurring on 
specific residues within loop and irregular folded regions exposed to solvent or near the metal 
centre of metalloproteins (Souza et al 1999).  Only a few proteins are capable of undergoing 
tyrosine nitration and the level of cellular 3-NT detected under basal conditions is low.  However, 
significant  increases  in  3-NT  can  be  detected  after  nitrosative  stress  associated  with 
cardiovascular disorders and during inflammation (Leeuwenburgh et al 1997; Shishehbor et al 
2003).  Proteins that change biological function upon nitration, such as α–synuclein and tau, are 
often  associated  with  pathological  conditions.    Nitrated  α–synuclein  and  tau  are  thought  to 
initiate aggregate formation in neurodegenerative diseases, such as Parkinson’s and Alzheimer’s 
(Souza et al 2000; Hodara et al 2004; Reynolds et al 2006).  It should also be considered that   39 
certain nitrated proteins exhibit no change in biological function, the scale of which is probably 
masked by difficulties in publishing negative data (Gole et al 2000). 
 
After  discovering  NO  as  a  physiological  signalling  molecule,  it  became  apparent  that 
cysteine  thiol  groups  could  couple  NO  through  S-nitrosylation,  a  modification  akin  to 
phosphorylation.  Due to the labile nature of this modification, early studies of S-nitrosylated 
proteins were performed in vitro using large quantities of exogenously supplied NO.  Within the 
last decade a new methodology that replaces the nitrosyl group with a more stable biotin-moiety 
called the biotin-switch assay, has allowed the analysis of endogenously nitrosylated proteins 
(Jaffrey and Snyder 2001).  Within a short time period, more than 100 proteins bearing cysteines 
that form S-nitrosothiols (SNO) have been identified (Jaffrey et al 2001).  The major contributor 
of this modification is NO generated by NOS, as well as nitrites and other higher order NO 
species.  Proteins can also be nitrosylated by the exchange of nitrosyl groups from other cellular 
SNOs in a process called transnitrosylation (Pawloski et al 2001).  The low-mass SNO S-nitroso-
glutathione  (GSNO)  is  metabolized  by  GSNO-reductase  and  is  the  major  source  of  cellular 
transnitrosylating SNO.   
 
Despite the expression of at least one NOS isoform in most cell types and that the majority 
of  proteins  contain  a  cysteine  residue,  S-nitrosylation  appears  to  be  a  highly  specific 
modification.  Many proteins that are S-nitrosylated often contain multiple cysteines but only one 
or very few are targeted by NO in vivo.  The specificity of cysteines targeted by NO is dependent, 
at  least  in  part,  on  the  presence  of  an  acid-base  consensus  motif  (Stamler  et  al  1997).  
Deprotonation of the thiol group to form a more reactive thiolate anion (RS
–) is suppressed and   40 
enhanced  by  the  presence  of  proximal  acidic  and  basic  groups,  respectively.    This  can  be 
enhanced  by  the  presence  of  Zn
2+  that  reduces  the  pKa  of  neighbouring  cysteine  thiols,  as 
observed for metalloproteins (Dudev and Lim 2002).  The presence of an acid-base motif may be 
determined  by  the  tertiary  or  quaternary  structure  of  a  protein,  such  as  for  caspase-3  and 
haemoglobin  therefore,  prediction  of  S-nitrosylation  sites  from  the  primary  sequence  is  not 
always possible (Hess et al 2001).  An additional mechanism involves the concentration of NO 
and  O2  within  hydrophobic  pockets,  resulting  in  the  formation  of  NO  species  that  readily 
nitrosylate nearby cysteines.  These hydrophobic pockets can reside within the protein tertiary 
structures  or  within  a  juxtamembrane  position,  as  with  the  Ryanodine  Receptor/Ca
2+-release 
channel (RyR1) and the NMDAR, respectively (Choi et al 2000; Nedospasov et al 2000; Sun et al 
2001; Hess et al 2005).  Metal-centres of proteins can also catalyse nitrosylation of intrinsic 
cysteine residues (eg haemoglobin) or cysteines on differing protein substrates (eg superoxide 
dismutase).  As discussed earlier, coupling of nitrosyl groups to cysteine residues can also occur 
by transnitrosylation.  This direct transfer of a nitrosyl group from other SNOs present in the cell 
is specified by protein-protein interactions. 
 
S-nitrosylation has been reported to regulate the activity of a number of proteins, affecting 
catalytic activity, protein-protein interaction and/or subcellular localisation (Hess et al 2005).  
The  enzymatic  activity  of  all  caspases,  and  certain  protein  tyrosine  phosphatases  (PTPs)  is 
inhibited by nitrosylation of critical cysteine residues within the active site (Mannick et al 2001).  
MAP kinases, including ASK1 (apoptosis signal-regulating kinase-1) and JNK (Jun N-terminal 
kinase) are also negatively regulated by S-nitrosylation however, other kinases such as Src (non-
receptor protein tyrosine kinase p60
Src) have enhanced activity upon nitrosylation (Akhand et al   41 
1999; Park et al 2000; Park et al 2004).  Similarly, S-nitrosylation of ion channels can either 
inhibit ion influx, such as the NMDAR, or enhance it, as observed with RyR1 (Choi et al 2000; 
Eu  et  al  2000).    Nitrosylation  can  also  enhance  GDP–GTP  exchange  of  certain  monomeric 
GTPases, including activation of p21
Ras and Dexras in neurons (Yun et al 1998; Jaffrey et al 
2002).    These  few  examples  illustrate  the  variety  of  effects  that  NO  can  have  on  protein 
functions, demonstrating its ability to act as a very flexible signalling molecule. 
 
1.4.3 S-nitrosylation: a reversible modification 
 
S-Nitrosylation  of  proteins  is  dependent  on  cellular  levels  of  NO  and  its  higher  oxide 
derivatives and on intracellular SNO content that is dictated largely by the tight regulation of 
NOS activity, expression and localisation.  However, removal of nitrosyl groups (denitrosylation) 
is also essential.  The finding that constitutively S-nitrosylated proteins, such as mitochondrial 
caspase-3  and  eNOS,  become  activated  upon  stimulus-coupled  denitrosylation  support  this 
mechanism (Mannick et al 1999; Ravi et al 2004).  
 
In  vitro  studies  have  identified  the  redox  proteins  glutathione-dependent  formaldehyde 
dehydrogenase (GS-FDH), protein disulphide isomerase (PDI) and the thioredoxin−thioredoxin 
reductase (Trx-TR) system as denitrosylases that reduce SNO levels (Nikitovic et al 1996; Liu et 
al 2001; Sliskovic et al 2005).  Both GS-FDH and PDI are capable of reducing GSNO to produce 
GSH and NO, thus providing an additional source of cellular NO (Liu et al 2001; Sliskovic et al 
2005).  Additionally, PDI is capable of forming a fairly stable intermediate (PDI-SNO) and is   42 
continuously secreted from NO-like endothelial cells, possibly providing a mechanism for intra- 
and intercellular transport of NO (Sliskovic et al 2005).  
 
The Trx-TR system reduces low molecular mass and protein S-nitrosothiols.  Unlike other 
redox  proteins  associated  with  denitrosylation,  both  Trx  and  TR  are  ubiquitously  and 
constitutively expressed in most cells types (Nikitovic and Holmgren 1996; Ravi et al 2004; 
Sengupta et al 2007).  Nitrosylated proteins that are reduced by Trx include glutathione, caspase-
3, albumin, metallothionenin and eNOS.  Trx-dependent denitrosylation has been observed in 
many species from yeast to humans, and more recently in Arabidopsis thaliana (Nikitovic et al 
1996; Ravi et al 2004; Stoyanovsky et al 2005; Tada et al 2008).  Trx contains a vicinal dithiol 
(Cys-X-X-Cys)  which  reduces  the  disulphide  bridges  of  substrate  proteins  through  a  mixed 
disulphide intermediate, and then forms a disulphide ring closure (Trx(SH)2) upon release of the 
reduced substrate.  Reduction of Trx(SH)2 back to Trx requires the NADPH-dependent enzyme, 
TR (Arner and Holmgren 2000).  The same two Trx cysteine residues are necessary for the 
reduction of S-nitrosolyated proteins with a mechanism that remains elusive (Fig 1.5) (Benhar et 
al  2008).    Trx  reduction  of  S-nitrosylated  proteins  also  exhibits  some  isoform  specificity.  
Notably, Trx-2 reduces the constitutively S-nitrosylated mitochondrial caspase-3 upon exposure 
of  cells  to  pro-apoptotic  stimuli,  whereas  Trx-1  maintains  a  low  basal  steady-state  level  of 
cytosolic SNO, including cytosolic caspase-3 (Benhar et al 2008). 
   43 
 
Figure 1.5 Mechanisms for reduction of SNO-proteins by Trx.  A. Initially, the N-terminal cysteine thiolate 
within  a  vicinal  dithiol  (Cys-X-X-Cys)  attacks  the  substrate  disulphide  bond  and  produces  a  mixed  disulphide 
intermediate.  Attack by the C-terminal cysteine thiolate transfers the disulphide link to Trx, (Trx-SH2) which results 
in reduction and release of the substrate.  Trx-SH2 is reduced back to Trx by NADPh-dependent TrxR.  B. A possible 
mechanism  for  denitrosylation  of  SNO-protein  by  Trx,  as  proposed  by  Benhar  et  al,  2008.    C.  An  alternative 
mechanism for denitrosylation of SNO-protein based on transnitrosylation. Taken from Benhar et al, 2008 
 
1.4.4 NO is a retrograde signal that influences learning and memory 
 
Learning results from changes in the efficacy of chemical synaptic transmission, and can be 
either  facilitative  (long-term  potentiation;  LTP)  or  depressive  (long-term  depression;  LTD).  
Short-term memory normally involves covalent post-translational modifications without de novo 
protein synthesis.  Long-term memory, lasting from days to years, requires initiation of gene   44 
transcription and presumably involves translocation of a signal from the synapse to the nucleus.  
Synaptic plasticity is predominantly localised to the presynaptic neuron leading to the popular 
theory that LTP requires a retrograde signal from the post-synaptic site back to the presynaptic 
neuron  (Arancio  et  al  1996;  Emptage  et  al  2003).    NO  is  both  water  and  lipid  soluble  and 
presumably capable of free diffusion between cells, making it a good candidate for a retrograde 
signal (Schuman and Madison 1991; Zhuo et al 1993). 
 
LTP  is  mostly  studied  in  the  CA1  pyramidal  neurons  of  the  hippocampus  following 
glutamate  stimulation  of  Schaffer  collaterals.    Glutamate  binding  to  α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionate  receptors  (AMPARs)  on  pyramidal  neurons  activate  voltage-
dependent NMDARs and induces Ca
2+ influx.  An increase in intracellular Ca
2+ results in the 
activation of secondary messenger cascades, including Ca
2+/calmodulin binding and activation of 
nNOS.  The CA1 pyramidal neurons release postsynaptic NO, which can then signal back to the 
original presynaptic sites or possibly to other adjacent synapses (Susswein et al 2004).  This 
hypothesis is supported by the ability of NO to induce LTP when paired with a weak tetanus not 
normally sufficient to cause LTP (Zhuo et al 1993).  Injection of membrane-impermeant NO 
scavengers into the presynapse are also sufficient to block LTP (Arancio et al 1996).  Analysis of 
NOS transgenic mice indicates that the absence of both eNOS and nNOS is associated with the 
disruption of LTP in the hippocampal CA1 region (Son et al 1996).  This implies that non-
neuronal cells that express eNOS may also be required for the establishment of LTP.  However, 
in discrete areas of the CA1 region, LTP remains unaffected by nNOS and eNOS disruption (Son 
et  al  1996).    Therefore,  additional  NO-independent  mechanisms  must  exist.    It  should  be 
considered that the role of NO in mediating LTP and the establishment of memories remains   45 
controversial as several studies failed to find NO-dependent effects on LTP (Bannerman et al 
1994a; Cummings et al 1994; Murphy et al 1994), or memory in the hippocampus (Bannerman et 
al 1994b; Tobin et al 1995). 
 
The molecular mechanism that underlies NO-mediated LTP in the hippocampus is still a 
matter of debate.  Pharmacological studies have demonstrated a requirement of activated sGC 
and PKG as secondary messengers of NO signalling for hippocampal LTP (Zhuo et al 1994; Son 
et al 1998).  One group observed that PKG activation is necessary within the presynatic terminus, 
further implicating NO as a retrograde messenger from the postsynaptic to the presynaptic neuron 
(Arancio et al 2001).  However, additional studies on hippocampal LTP favour NO induced 
ADP-ribosylation  of  proteins,  with  no  effect  observed  upon  blocking  of  the  cGMP  pathway 
(Schuman et al 1994; Kleppisch et al 1999).  NO can also suppress LTP in post-synaptic neurons 
by reducing the efficacy of NMDA receptors (Murphy and Bliss 1999).  The discrepancies on 
NO  and  its  involvement  in  hippocampal  LTP  may  be  due  to  differences  in  experimental 
conditions and protocols, as well as the use of different animal models at differing stages of 
development. 
 
The molecular mechanisms underlying learning and memory have also been extensively 
studied in the cerebellum, where LTD can be observed in Purkinje cells following activation of 
presynaptic  parallel  fibres.    Purkinje  cells  are  inhibitory  neurons  therefore,  a  reduction  of 
Purkinje activity following LTD will lead to increased activity of target neurons.  As observed 
with hippocampal LTP, increased NO or Ca
2+ levels within postsynaptic Purkinje neurons are 
sufficient for the establishment of LTD through an sGC-dependent mechanism (Lev-Ram et al   46 
1997).  LTP in the cerebellum is also NO dependent however, it does not require cGMP or cAMP 
signalling (Lev-Ram et al 2002).  NO produced in Purkinje cells can act as a retrograde signal to 
induce LTP in presynaptic parallel fibres (Jacoby et al 2001).  This is analogous to NO produced 
in CA1 neurons, which serves as a retrograde signal that activates sGC in presynaptic parallel 
fibres.  The majority of NO studies in the cerebellum often rely heavily on NO donors and 
manipulation of the cGMP pathway, with little or no use of NOS inhibitors (Lev-Ram et al 1997; 
Smith et al 2003). Therefore caution should be taken when considering the effects of NO on LTD 
and learning in the cerebellum. 
 
1.4.5 NO and cell survival – a Janus molecule 
 
NO is infamously regarded as a Janus molecule, as it has been implicated in both pro- and 
anti-apoptotic signalling responses.  Cells maintained in basal conditions generate a low level of 
NO that activates anti-apoptotic pathways necessary for cell survival.  An increased level of NO 
following exposure to apoptotic stimuli initiates both pro- and anti-apoptotic mechanisms and 
under these conditions cell survival will depend on the level of NOS activation, with a higher 
concentration of cellular NO favouring a pathologic outcome. 
 
It  is  well  established  that  a  number  of  apoptotic  stimuli  induces  nitrosylation  of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), leading to its nuclear translocation and 
cell death (Sawa et al 1997).  Nuclear translocation of nitrosylated GAPDH is dependent on its 
interaction with an E3 ubiquitin ligase, Siah1.  GAPDH increases Siah1 stability and nuclear 
accumulation, facilitating Siah1-dependent degradation of nuclear proteins and apoptosis (Hara et   47 
al 2005).  NO-mediated apoptosis is often studied in models of stroke and neurodegenerative 
diseases such as Parkinson’s and Alzheimer’s disease.  Matrix metalloproteinase-9 (MMP-9) and 
parkin are examples of pro-apoptotic proteins positively regulated by NO signalling (Gu et al 
2002; Chung et al 2004).  MMP9 activity requires S-nitrosylation of a specific cysteine residue 
that disrupts its coordination with Zn
2+ allowing the entry of the obligate catalytic ligand H2O 
(Gu et al 2002).  Further cysteine oxidation to sulphinic or sulphonic acid irreversibly activates 
MMP9 resulting in extracellular proteolytic cascades and apoptosis (Gu et al 2002).  Parkin, an 
E3 ubiquitin ligase, is inactivated upon S-nitrosylation and is thought to be responsible for the 
intracellular accumulation of misfolded proteins and apoptotic death of dopaminergic neurons in 
patients affected by Parkinson’s disease (Chung et al 2004). 
 
Interestingly, apoptosis mediated by caspase activation requires a mechanism that involves 
denitrosylation.  Caspases belong to a family of cysteine proteases associated with initiation and 
execution  of  apoptotic  pathways.    They  are  constitutively  expressed  as  inactive  caspase 
zymogens,  which  in  response  to  pro-apoptotic  signals  are  cleaved  to  form  active  caspase 
enzymes.  Under basal conditions, caspases are inhibited by nitrosylation of a critical active site 
cysteine residue (Dimmeler et al 1997; Kim et al 1997; Li et al 1997; Mannick et al 1999).  S-
nitrosylation  of  caspase-3  occurs  predominantly  within  a  subpopulation  associated  with 
mitochondria  and  is  essential  for  inhibiting  apoptosis  (Mannick  et  al  1999).    Caspase-3  is 
denitrosylated following Fas stimulation, which results in caspase activation and initiation of 
apoptosis (Mannick et al 1999; Matsumoto et al 2003).  
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Conversely, pro-apoptotic stimuli can inhibit pro-apoptotic proteins through NO signalling, 
thus acting as a negative feedback mechanism.  Increased NO synthesis following interferon-γ 
stimulation  induces  nitrosylation  of  ASK1,  which  prevents  ASK1  from  binding  to  substrate 
kinases and blocks apoptosis (Park et al 2004).  Stimulation of glutamate-dependent NMDAR 
induces Ca
2+ influx, which leads to activation of nNOS and NO synthesis (Garthwaite et al 1988).  
Subsequent  S-nitrosylation  of  NMDARs  inhibits  further  Ca
2+  influx,  thereby  preventing 
excitotoxicity and activation of pro-apoptotic pathways (Lipton et al 1993; Choi et al 2000).  
Interestingly, NMDAR activation inhibits expression of the Trx inhibitor, Txnip, thus enhancing 
an antioxidant system known to reduce intracellular SNO (Papadia et al 2008).  Similarly, Fas 
stimulation  leads  to  S-nitrosylation  of  FLICE  inhibitory  protein  (FLIP)  preventing  its 
ubiquitination and proteasomal degradation (Chanvorachote et al 2005).  FLIP interferes with 
caspase-8 binding to the Fas receptor complex, which inhibits caspase-8 activation and apoptosis 
(Chanvorachote  et  al  2005).   Other  stimuli,  including  neurotrophin  signalling  in  the  nervous 
system, induces NOS activation and promotes cell survival. 
 
Opposite  responses  to  NO  signalling  may  be  due  to  differences  of  subcellular  NO 
concentrations and compartmentalisation of NOS activity.  Basal S-nitrosylation of proteins when 
intracellular NO levels are low may be facilitated by co-localisation of substrates with NOS.  For 
instance, caspase-3 directly associates with all three isoforms of NOS.  S-nitrosylated proteins 
also  bind  adaptor  proteins  or  are  located  within  microdomains  containing  NOS,  such  as  the 
intermembrane space in mitochondria.  Interestingly, Fas stimulation increases nitrosylation of 
cytosolic FLIP, while inducing denitrosylation of mitochondrial caspase-3.  The ability of Fas 
signalling to induce both addition and removal of the same modification may be achieved by   49 
segregating these opposite mechanisms to subcellular compartments, such as nitrosylation within 
the cytoplasm and denitrosylation in mitochondria. 
 
1.4.6 NO and cell proliferation 
 
nNOS is the primary isoform expressed in neurons however, specific populations within the 
CNS express also eNOS (astrocytes and vascular endothelial cells) and iNOS (microglia and 
astrocytes)  (Dinerman  et  al  1994b;  Heneka  and  Feinstein  2001).    Neuronal  NO  has  been 
implicated in a number of neuronal processes, including proliferation, survival, differentiation, 
ischemic cell death and neurodegeneration.  Neurotrophins are important mediators of neuronal 
proliferation and differentiation.  Exposure of neuronal cultures and neuronal-derived cell lines to 
either NGF or BDNF induces expression of NOS and stimulates NO synthesis (Peunova and 
Enikolopov 1995; Cheng et al 2003; Riccio et al 2006).  NO has anti-proliferative effects in 
cerebellar granule cells, as well as in several neuronal-derived cell lines without affecting cell 
viability or apoptosis (Peunova and Enikolopov 1995; Murillo-Carretero et al 2002; Ciani et al 
2004).  Inhibition of NOS activity has also been shown to delay differentiation of PC12 cells and 
neural progenitor cultures (Rialas et al 2000; Murillo-Carretero et al 2002; Cheng et al 2003). 
 
Neurogenesis persists in two regions of the adult brain, the SVZ and the subgranular zone 
of the dentate gyrus in the hippocampus.  Within these regions discrete populations of neurons 
express nNOS, which are in very close proximity to neuronal precursor cells.  Neuroblasts from 
the SVZ migrate tangentially along the rostral migratory stream (RMS) to the olfactory bulb 
where they differentiate to form mature interneurons.  NOS positive cells are found along the   50 
RMS,  with  abundant  processes  that  intermingle  with  the  migrating  precursor  cells  (Moreno-
Lopez et al 2000).  Interestingly, progenitors in the adult SVZ that do not initially express NOS 
become NOS positive as they migrate to the olfactory bulb, suggesting that NO may play a role 
in  neuronal  differentiation.    Both  genetic  ablation  of  nNOS  and  systemic  or  intraventricular 
infusion of NOS inhibitors augmented the number of cells generated within the SVZ and dentate 
gyrus of adult mice (Moreno-Lopez et al 2004; Matarredona et al 2004; Packer et al 2003).  
Moreover, NO inhibits proliferation of neuronal cultures obtained from the SVZ of postnatal 
mice without affecting cell survival (Matarredona et al 2004; Torroglosa et al 2007).   
 
1.4.7 Role of NO in the development of the nervous system 
 
In the developing nervous system nNOS is transiently expressed in restricted regions of the 
brain, including the embryonic cortical plate and the olfactory epithelium (Bredt and Snyder 
1994).  Within these populations, nNOS is not detectable during the early phases of neurogenesis 
when  neural  stem  cells  are  actively  proliferating.    nNOS  mRNA  is  first  detected  in  neural 
precursor cells at E10, with levels progressively increasing as precursors differentiate to form 
post-mitotic  mature  neurons  (Bredt  and  Snyder 1994;  Ogura  et  al  1996;  Cheng  et  al  2003).  
Neurotrophin-dependent precursors in sensory and sympathetic ganglia also express high levels 
of nNOS when they exit the cell cycle and differentiate (Bredt and Snyder 1994; Thippeswamy 
and  McKay  2005).    nNOS  expression  sharply  decreases  postnatally  once  the  axons  have 
established connections with their peripheral targets (Thippeswamy and McKay 2005). 
   51 
The observation that NO triggers growth arrest in NGF-induced differentiating PC12 cells 
provided  the  initial  indication  that  NO  is  an  important  regulator  of  neuronal  development 
(Peunova  and  Enikolopov  1995;  Phung  et  al  1999).    Similarly,  reduced  proliferation  and 
increased  differentiation  was  observed  in  neuroblastoma  cell  lines  NB69  and  Sk-N-BE  upon 
exposure to endogenous and exogenous NO (Murillo-Carretero et al 2002; Ciani et al 2004).  
Exogenous application of NO donors and NOS inhibitors to primary cultures of cerebellar and 
cortical neurons also demonstrated that NO inhibits proliferation and promotes differentiation 
(Cheng  et  al  2003;  Ciani  et  al  2004).    Stimulation  of  mouse  cortical  neuroepithelial  cluster 
cultures  with  either  NO  donors  or  BDNF  decreases  cell  proliferation  and  increases  neuronal 
differentiation  (Cheng  et  al  2003).    Interestingly,  BDNF  application  increases  expression  of 
nNOS indicating that it may act as a positive feedback loop for NO signalling (Cheng et al 2003).  
Application of NO inhibitors to embryonic brain slice cultures inhibits granule cell migration and 
increases proliferation in the cerebellar cortex (Tanaka et al 1994).  Similarly, treatment of rat 
pups (postnatal day 3) with NOS inhibitors increases proliferation of cerebellar precursor cells 
(Ciani et al 2006). 
 
These data strongly implicates a role of NO in the development of the CNS however, apart 
from early work performed by Tanaka et al., studies in vivo have primarily focused on the role of 
NO in adult neurogenesis (Tanaka et al 1994).  Developmental processes require long-lasting, 
tightly regulated changes in gene transcription.  It is therefore, not surprising that NO signalling 
is capable of affecting gene expression. 
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1.4.8 Transcriptional targets of NO 
 
Recent studies have suggested that NO signalling plays an important role in regulating the 
expression  of  multiple  genes  by  activating  promoter  cis-elements  (Hemish  et  al  2003; 
Dhakshinamoorthy et al 2007).  NO modulates gene expression through activation of multiple 
transcription factors including CREB, N-Myc, NF-κB, p53 and in bacteria, OxyR.  A role of NO 
in regulating gene expression was first demonstrated for CREB.  Ca
2+-dependent NO signalling 
induced the expression of the CREB-regulated gene, Fos (Peunova and Enikolopov 1993). NO-
dependent activation of CREB regulates various neuronal processes, including neuronal survival, 
differentiation and LTP (Lu et al 1999; Ciani et al 2002; Puzzo et al 2005).  Several groups have 
demonstrated  that  NO  signalling  and  activation  of  the  sGC/PKG  pathway  results  in  CREB 
phosphorylation on Serine 133 (Ciani et al 2002; Nagai-Kusuhara et al 2007).  Phosphorylation 
of CREB is essential for its activation and is necessary and sufficient for promoting neuronal 
survival (Ciani et al 2002; Nagai-Kusuhara et al 2007).  Similarly, LTP in the CA1 region of the 
hippocampus  is  dependent  on  activation  of  NO  and  sGC/PKG  pathways,  followed  by 
phosphorylation of CREB (Lu and Hawkins 2002).  NO can also regulate CREB activity through 
a  mechanism  independent  of  CREB  phosphorylation.    Upon  exposure  of  cortical  neurons  to 
BDNF, NO mediates the binding of CREB to target gene promoters (Riccio et al 2006).  These 
conflicting mechanisms of NO-mediated CREB activation may reflect differences in neuronal 
cell type, developmental stage and experimental conditions. 
 
N-Myc  is  an  oncogene  and  a  transcription  factor  that  is  essential  for the  expansion  of 
progenitor  cell  populations  during  normal  brain  development  (Contestabile  2008).    NO  and   53 
cGMP/PKG signalling have both been demonstrated to inhibit N-Myc expression, as well as 
proliferation rates of neonatal precursor granule neurons (Ciani et al 2004; Ciani et al 2006).  
Similarly,  neuroblastoma  cell  line  SK-N-BE  and  embryonic  carcinoma  stem  cells  exhibited 
reduced  transcription  of  genes  associated  with  tumour  progression  following  a  NO-mediated 
suppression  of  N-Myc  (Park  et  al  2002;  Ciani  et  al  2004;  Contestabile  2008).    NO-based 
treatments  are  therefore,  considered  as  potential  novel  therapeutic  tools  for  neural-derived 
tumours.  Despite evidence that NO regulates both CREB and N-Myc activity, S-nitrosylation of 
either transcription factor has not been observed.  Interestingly, the transcription factor AP1 binds 
to  DNA  in  a  redox-sensitive  manner.    NO  inhibits  AP1  binding  to  DNA  in  vitro  through 
nitrosylation of two cysteine residues within the DNA binding domain of its components, c-jun 
and c-fos (Nikitovic et al 1998).  Moreover, NO can negatively regulate AP1 binding through 
addition of glutathione (S-glutathionylation) to a specific cysteine within the active site of c-jun 
(Klatt  et  al.  1999).    Interestingly,  upregulation  of  c-jun  expression  following  neurotrophin 
deprivation of sympathetic neurons has been linked to cell death (Ham et al 1995); therefore NO 
inhibition of c-jun may be beneficial for cell survival.  NO induces expression of the c-fos-
regulated gene tyrosine hydroxylase, as well as induction of Fos itself, in a number of neuronal 
systems (Wu et al 2000; Najimi et al 2002; Chan et al 2004; Riccio et al 2006).  This may serve 
as  a  negative  feedback  mechanism,  with  NO  initially  inducing  expression  of  Fos  and  later 
inhibiting AP1 activity through S-nitrosylation of c-fos and c-jun. 
 
Nitric oxide regulates transcription factors containing a zinc-finger domain, including Egr-1 
and NF-κB, by disrupting the zinc-sulphur clusters essential for zinc binding and subsequent 
targeting to DNA.  However, in living cells there is no direct evidence that zinc mobilization   54 
occurs upon NO synthesis.  The expression and activity of Egr-1 has been shown to increase in 
neuronal-derived  PC12  and  SH-SY5Y  cells  following  exposure  to  NO  donors,  although  the 
mechanism by which NO mediates this transcriptional activation remains unclear (Thiriet et al 
1997;  Cibelli  et  al  2002).    In  mammals,  NF-κB  is  constitutively  expressed  as  a  p50/p65 
heterodimer and is retained within the cytoplasm by its inhibitor IκB.  Upon IκB phosphorylation 
and  subsequent  proteolysis,  NF-κB  translocates  into  the  nucleus  and  binds  to  target  gene 
promoters.   In  immune  cells,  S-nitrosylation  of p50  and  tyrosine  nitration  of  p65  negatively 
regulates NF-κB binding to DNA (Marshall and Stamler 2001; Park et al 2005).  NO signalling 
further inhibits NF-κB function by reducing proteasomal degradation of its inhibitory component, 
IκB (Marshall and Stamler 2002; Reynaert et al 2004).  Conversely, striatal and spinal cord 
neurons show an increase of NF-κB binding to DNA upon NO signalling (Simpson and Morris 
1999; Miscusi et al 2006).   
 
Conflicting data on the regulation of AP1 and NF-kB suggest that NO may regulate gene 
expression  independent  of  transcription  factor  S-nitrosylation.    Two  recent  studies  have 
demonstrated that NO elicits a very broad level of control on transcriptional regulation (Hemish 
et  al  2003;  Dhakshinamoorthy  et  al  2007).  NO  is  capable  of  modulating  important  cellular 
processes, including cell cycle exit and differentiation, which require tightly regulated and large-
scale changes in gene expression.  However, the molecular target of NO that would enable such a 
global change in transcription has yet to be elucidated. 
   55 
1.5 Aims and Questions 
 
A major aim of my thesis was to test whether neurotrophin activates NO signalling in 
nuclei of developing neurons.  I utilised a NO-sensitive fluorescent dye, 4-amino-5-methylamino-
difluororescein-2’7’-diacetate  (DAF-FM  DA),  to  visualise  NO  synthesis  in  neurons.    I 
demonstrated that BDNF treatment of mouse embryonic cortical neurons induces accumulation 
of NO within both nuclear and cytoplasmic compartments.  Neurotrophins are responsible for 
stable long-term changes in gene expression, which requires chromatin remodelling.  This begged 
the  question,  does  neurotrophin-induced  NO  signalling  modulate  gene  transcription  during 
development?  Analysis of proteins modified by NO was performed using a complex biochemical 
assay, the biotin-switch assay, which replaces labile cysteine nitrosyl groups with a stable biotin-
moiety.  By employing this technique, I demonstrated that exposure of cortical neurons to BDNF 
induces S-nitrosylation of HDAC2 at two specific cysteine residues.  ChIP is a procedure that 
determines  whether  a  given  protein  is  associated  with  a  specific  region  of  DNA.    ChIP 
experiments were performed to test whether HDAC2 or acetylated histones were detectable at 
CREB regulated gene promoters.  ChIP experiments revealed that BDNF stimulation induced a 
substantial loss of nitrosylated HDAC2, hyperacetylation of histones H3 and H4 and increased 
expression  of  endogenous  genes.    Finally,  I  demonstrated  that  nitrosylation  of  HDAC2  is 
necessary for normal dendritic growth in vitro and radial migration of cortical progenitor cells in 
vivo.   56 
Chapter 2  BDNF induces nuclear NO accumulation in cortical 
neurons 
 
Neurotrophin  stimulation  and  NO  signalling  are  important  modulators  of  cortical 
neurogenesis.    Both  BDNF  and  NO  signalling  inhibit  proliferation  and  promote  neuronal 
differentiation (Barnabe-Heider and Miller 2003; Cheng et al 2003; Packer et al 2003; Moreno-
Lopez  et  al  2004;  Bartkowska  et  al  2007).    Importantly,  expression  of  BDNF  and  NOS  is 
spatially restricted within identical regions of the cortex during development (Bredt and Snyder 
2004;  Cheng  et  al  2003).    The  stimulatory  effect  of  BDNF  on  differentiation  of  neuronal 
precursor cells can be blocked using NOS inhibitors, thereby implicating a direct role of NO on 
neurotrophin-induced cortical development (Cheng et al 2003).  BDNF induces nNOS expression 
and NO synthesis in neurons (Cheng et al 2003; Nott et al 2008), however, there are no direct 
evidence of BDNF-dependent accumulation of NO in neurons. 
 
NO synthesis was directly visualise in cortical neurons using the fluorescent probe DAF-
FM DA, and was performed in collaboration with Mr James Robinson (Fig. 2.1).  Embryonic 
cortical  neurons  were  incubated  with  the  membrane-permeant,  DAF-FM  DA,  which  is 
deacetylated in the cytoplasm to form the cell-impermeable non-fluorescent DAF-FM (Fig. 2.1).  
Any excess probe was removed by washing the cultures with fresh medium prior to treatment 
with  BDNF  (Fig.  2.1).    The  fluorescence  quantum  yield  of  DAF-FM  is  low  (~0.005)  but 
increases about 160-fold after reacting with NO.  DAF-FM fluorescence is detected within a 
spectrum similar to flourescein at emission/excitation maxima of 495/515nm (Kojima et al 1998).  
E17 rat cortical neurons were either stimulated with BDNF (75ng/ml) for 10 minutes or left   57 
untreated and subjected to DAF-FM staining (Fig. 2.1).  Neurons exposed to BDNF exhibited a 
two-fold increase in the number of DAF-FM positive cells when compared to cultures treated 
with vehicle.  This corroborates earlier studies that showed that BDNF induces NO synthesis in 
neurons (Cheng et al 2003; Riccio et al 2006).  Confocal imaging revealed that NO could be 
detected in both cytoplasmic and nuclear compartments of cortical neurons.  This is the first 
evidence  that  NO  accumulates  within  the  nucleus  and  has  important  implications  for  NO 
modulation of nuclear proteins.  In unstimulated neurons, a basal level of NO was detected, 
which may be a consequence of NMDA receptor activation induced by washing the cells during 
the DAF-FM protocol (Fig. 2.2, 2.3).  To reduce the background fluorescence, neurons were 
cultured  in  a  reduced-serum  medium  containing  the  NMDA  antagonist,  DL-2-amino-5-
phosphonovaleric  acid  (DL-AP5)  for  16  hours  prior  to  stimulation.    Treatment  of  neuronal 
cultures with DL-AP5 greatly reduced basal DAF-FM fluorescence however, a residual amount 
of fluorescence persisted in 20% of unstimulated neurons.  Detection of residual NO under basal 
culture  conditions  may  be  a  result  of  endogenously  synthesised  BDNF  that  may  stimulate 
neurons  in  a  paracrine  and  autocrine  manner  (Maisonpierre  et  al  1990;  Ernfors  et  al  1992; 
Fukumitsu et al 1998).  It is important to note that the percentage of NO-positive cells never 
exceeds  50%,  even  in  cultures  treated  with  exogenous  BDNF.    This  result  reflects  previous 
observations that during development, cells positive for nNOS are observed in the intermediate 
zone and cortical plate, but are absent in progenitor cells of the VZ and SVZ (Cheng et al 2003). 
 
NO accumulation in cortical neurons following treatment with BDNF is extremely rapid 
and is detected within minutes of stimulation (Fig. 2.2, 2.3).  The fast rate of accumulation of NO 
in neurons may reflect the requirement of Ca
2+ for nNOS activation and rapid kinetics of Ca
2+   58 
signalling.  To test whether BDNF-dependent NO accumulation in neurons is generated by nNOS 
activation,  cultures  were  pre-treated  with  the  specific  nNOS  inhibitor  N-O-propyl-L-arginine 
(NPA).    The  number  of  DAF-FM  positive  cells  in  cultures  pre-treated  with  NPA  and 
subsequently exposed to BDNF was dramatically lower, when compared to cultures treated with 
BDNF (Fig. 2.2, 2.3).  This result demonstrates that specific inhibition of nNOS blocks BDNF-
dependent  NO  synthesis  in  neurons  (Fig.  2.2,  2.3),  thereby  supporting  a  model  by  which 
neurotrophin stimulation of embryonic cortical neurons leads to nNOS activation and increased 
intracellular NO. 
 
Since the discovery of NO as a physiological signal, a multitude of proteins regulated by 
this small gaseous molecule have been identified (Hess et al 2001).  The prevalent mechanism of 
NO-dependent modulation of protein functions is through S-nitrosylation, a covalent modification 
of  cysteine  thiol  groups.    A  major  obstacle  to  the  detection  of  endogenously  S-nitrosylated 
proteins is the labile nature of this posttranslational modification, as nitrosothiol groups are easily 
lost  upon  exposure  to  UV  light  and  reducing  agents  such  as  glutathione,  ascorbic  acid  and 
reducing  metal  ions.    An  additional  technical  obstacle  in  detecting  endogenous  nitrosylated 
proteins is the lack of reliable anti-nitrosocysteine antibodies.  The development of the biotin-
switch assay by Jaffrey and Snyder in 2001 was a seminal step that allowed the detection of S-
nitrosylated proteins by substituting the labile nitrosothiol group with the more stable biotin-
moiety  (Fig.  2.4)  (Jaffrey  and  Snyder  2001).    This  complex  biochemical  assay  requires  the 
neutralization of free cysteine thiol groups with the thiol-specific methylthiolating agent, methyl 
methanethiosulphonate (MMTS).  Treatment with ascorbic acid specifically reduces nitrosylated 
cysteines to free thiol groups, while cysteines in alternative oxidative states remain unaffected   59 
(Forrester et al 2007).  Finally, the newly-formed free thiols are labelled using the sulphidyl-
specific  biotinylating  agent,  N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)-propionamide 
(biotin-HPDP)  (Jaffrey  and  Snyder  2001).    As  a  result,  proteins  that  were  originally  S-
nitrosylated are labelled with a stable biotin-moiety, allowing separation on an acrylamide gel 
and  western  blot  analysis.    Alternatively,  biotinylated  proteins  can  be  precipitated  using 
streptavidin  conjugated  to  agarose  beads,  as  streptavidin  has  a  high  affinity  for  biotin.    The 
biotinylated protein is eluted from the beads and candidate proteins are individually detected by 
western blotting. 
 
To  investigate  whether  BDNF-induced  NO  accumulation  results  in  S-nitrosylation  of 
endogenous proteins, cortical neurons were exposed to BDNF (75ng/ml) for 10 and 30 minutes, 
respectively and cell lysates were subjected to the biotin-switch assay followed by biotin western 
blotting.  I observed that BDNF stimulation of embryonic cortical neurons induced nitrosylation 
of many endogenous proteins.  Exposure of neurons to BDNF for 10 minutes resulted in the 
appearance of nitrosylated proteins of 110, 90 and 75 KDa, whereas after 30 minutes of BDNF 
treatment prominent bands were observed at 35 and 17 KDa (see red arrows, Fig. 2.5).  This 
demonstrates that BDNF-dependent NO synthesis results in S-nitrosylation of many proteins in a 
time dependent manner.  A possible explanation is that nitrosylation of certain proteins may 
require higher cellular concentrations of NO.  These cysteine residues may be buried within 
hydrophobic pockets and are less exposed to intracellular NO however, once nitrosylated, they 
may form more stable modifications that persist for longer.  The accumulation of NO as a result 
of endogenous nNOS activation requires elevated levels of intracellular Ca
2+.  To test whether 
increased  intracellular  Ca
2+  concentration  induces  protein  S-nitrosylation  in  neurons,  cortical   60 
cultures  were  exposed  to  the  Ca
2+  ionophore  A23187.    Stimulation  of  cortical  neurons  with 
A23187 (50nM) increased protein S-nitrosylation similarly to BDNF treatment (Fig. 2.5).  This 
result suggests that BDNF-dependent S-nitrosylation in neurons requires nNOS activation as a 
source of NO.  
 
BDNF stimulation of cortical neurons induces NO accumulation within both the cytoplasm 
and the nucleus, resulting in nitrosylation of many endogenous proteins.  Interestingly, in situ 
nitrosocysteine immunostaining of lung epithelial cells revealed significantly higher levels of 
nitrosylated proteins within the nucleus, when compared to the cytoplasmic compartment (Ckless 
et al 2004).  However, nitrosylation of nuclear proteins has not been firmly established.  To 
determine  whether  nitrosylation  of  nuclear  proteins  occurs  in  cortical  neurons,  nuclear  and 
cytoplasmic extracts were exposed to GSNO for 30 minutes and subjected to the biotin-switch 
assay followed by anti-biotin western blot.  Treatment of neuronal nuclear fractions with NO 
donors induced S-nitrosylation of multiple proteins, with prominent bands observed at 90, 75, 38, 
and 25kDa (Fig. 2.6).  Importantly, the S-nitrosylated proteins observed in the nuclear fraction 
were distinct from those found in the cytoplasm (Fig. 2.6).  Nuclear translocation of proteins 
induced by cytoplasmic NO signalling has been demonstrated in a number of cases either through 
direct nitrosylation, such as GAPDH (Hara et al 2005), or through nitrosylation of regulatory 
factors, such as HDAC4/5 (Sengupta et al 2004).  In contrast, nitrosylation of proteins that reside 
predominantly within the nucleus, such as the class I HDACs, has never been observed.  The 
finding that NO accumulates within the nucleus opens the possibility that S-nitrosylation may 
occur while proteins are localised in the nucleus.  The ability of NO to modify nuclear proteins in   61 
situ  implies  that  NO  participates  directly  to  various  nuclear  functions,  including  gene 
transcription, DNA replication and repair.   62 
Figure 2.1 Schematic of DAF-FM-DA protocol. Step 1.  Cells were loaded with membrane 
permeable  DAF-FM-DA  (orange  cricles)  for  30  mins.    Step  2.   The  plates  were  washed  to 
remove excess DAF-FM-DA and incubated for 15 minutes to allow the production of membrane 
impermeable DAF-FM (purple cricles).  Step 3.  Cells were treated with BDNF (green circles), 
which induced nNOS activation and NO synthesis (red circles) Step 4.  NO reacts with DAF-FM 
to produce a fluorescent compound (yellow stars).  Neurons were fixed for 15 mins with 4% 
formaldehyde and images were captured within 24 hours using confocal microscopy. 
 
Figure 2.2 BDNF stimulates nuclear accumulation of nitric oxide production in cortical 
neurons. Cortical neurons were loaded with DAF-FM (10µM, 30 min) and exposed to either (i) 
BDNF (100ng/µL, 10 min), (ii) NPA (300µM, 30 min), (iii) NPA followed by BDNF, or (iv) 
vehicle (Ctrl) (lower panels).  Cells were stained using CellTracker and Hoescht to visualise cell 
morphology and nucleus, respectively (upper panels).  Nitric oxide is detected upon reaction with 
DAF-FM  at  emission/excitation  maxima  of  495/515  nm.    Images  were  captured  on  a  Leica 
DM2500 confocal microscope using an ACS APO 40x/1.15 oil objective lens. Scale bars, 25 µm 
(top panels) and 75 µm (lower panels). 
 
Figure 2.3 Quantitative analysis of DAF-FM experiment (Fig 2.1).  Analysis performed on 
images  captured  with  an  Axioplan  2  fluorescence  microscope  using  an  ‘EC  Plan  Neofluar’ 
10x/0.3 air objective lens and FS10 (GFP) filter.  Data represents the number of DAF positive 
cells normalised to the total number of cells, +/- SEM; n=3. 
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Figure 2.4 Schematic of biotin-switch assay.  Step 1.  Reduced thiols were blocked by 
using the thiol-specific methylthiolating agent, MMTS.  Excess blocking agent was removed by 
acetone precipitation.  Step 2.  Nitrosylated cysteine residues were reduced to free thiol groups 
using  ascorbic  acid.    Step  3.    Reduced  cysteines  were  labelled  using  the  thiol-specific 
biotinylating agent, biotin-HPDP.  Proteins that were initially S-nitrosylated are now labelled 
with a biotin-moiety. 
 
Figure  2.5  Protein  S-nitrosylation  is  induced  in  embryonic  cortical  neurons  upon 
neurotrophin stimulation.  Neurons were exposed to BDNF (75ng/ml for the indicated times), 
A23817 (50ng/ml, 20 mins), GSNO (100µM, 30 mins) or vehicle (Ctrl) and processed using the 
biotin-switch  protocol.    Positive  control  substrate  obtained  from  the  NitroGlo  Nitrosylation 
Detection  Kit  (PerkinElmer  Life  Science,  USA)  was  subjected  to  GSNO  (100µM,  Ctrl+)  or 
vehicle (Ctrl-) and processed using the biotin-switch protocol.  Samples were subjected to anti-
biotin western blot analysis.  Anti-HDAC2 western blot indicates equal loading (bottom panel).  
Red arrows indicate stimulus-induced S-nitrosylation of cortical proteins; n=3. 
 
Figure 2.6 Nuclear proteins are S-nitrosylated in cortical neurons upon exposure to NO 
donors.  Nuclear and cytoplasmic extracts of cortical neurons were exposed to GSNO (100µM, 
30 mins) in vitro and subjected to the biotin-switch assay.  Extracts were subjected to anti-biotin 
western blot analysis, and the purity of fractions was assessed using anti-histone H4 western blot 
(bottom panel). Red arrows indicate proteins that are nitrosylated after BDNF stimulation; n=3.  
NE, nuclear extract; WCL, whole cell lysate; CE, cytoplasmic extract. 
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Chapter 3  Histone deacetylase 2 is a nuclear target of NO 
 
A common factor to physiological processes regulated by NO during the development of 
the  nervous  system  is  the  requirement  for  profound  and  long-lasting  changes  in  gene 
transcription.  Exposure of cells to NO donors induces the transcription of a large number of 
genes through the binding of transcription factors to various cis-activating elements, including 
CRE, AP1, AP2, BRN-3, EGR, E2F1 and Sp1 (Hemish et al 2003; Dhakshinamoorthy et al 
2007).  Genes activated by NO regulate a broad range of genes involved in cell signalling, cell 
cycle, transcription, stress response, protein degradation, oxidative stress and apoptosis (Hemish 
et al 2003).  The large number of transcription factors activated and the broad range of genes 
induced suggest that NO may signal at an epigenetic level, reflecting the broad impact that NO 
has on neuronal physiology.  Binding of the transcription factors CREB and N-Myc to DNA is 
regulated by NO and is not dependent on S-nitrosylation of these transcription factors (Riccio et 
al  2006;  Contestable  et  al  2008).    Epigenetic  modifications  of  histone  tails,  such  as  lysine 
acetylation, result in chromatin remodelling that increases accessibility of transcription factors 
and  gene  activation.    Conversely,  repressive  complexes  induce  gene  repression  by  removing 
these  epigenetic  modifications.    Transcription  factor  binding  and  activation  during  cortical 
differentiation requires inactivation of various repressive complexes.  Activation of neural genes 
involves  coordinated  dissociation  of  repressive  complexes  containing  deacetylase  proteins, 
including HDAC1 and HDAC2 (Ballas and Mandel 2005; Hermanson et al 2002; Ju et al, 2004).  
A recent study has indicated that NO modulates nuclear shuttling of class II HDACs (Illi et al 
2008), which poses the question of whether nuclear class I HDACs are also regulated by NO. 
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During  the  development  of  the  CNS  class  I  HDACs  are  expressed  in  differentiating 
progenitor  cells  (Ajamian  et  al  2003;  Shaked  et  al  2008).    Notably,  HDAC2  expression  is 
maintained in both proliferating progenitor cells and differentiating neuronal precursors of the 
neocortex  (Shaked  et  al  2008;  Riccio  et  al  2006).    To  determine  whether  HDAC2  is  S-
nitrosylated  in  embryonic  cortical  neurons  upon  neurotrophin  stimulation,  E17  rat  cortical 
cultures were exposed to BDNF (75ng/ml) for 5, 15 and 60 minutes.  Cell lysates were processed 
using the biotin-switch assay, followed by precipitation with streptavidin and HDAC2 western 
blotting.    I  observed  that  stimulation  of  cortical  neurons  with  BDNF  induced  a  robust  S-
nitrosylation of endogenous HDAC2.  S-nitrosylation of HDAC2 was detected within 5 minutes 
and accumulated progressively with increased BDNF exposure up to 1 hour (Fig. 3.1, 3.2).  This 
is the first example of a S-nitrosylated nuclear protein and provides strong evidence that NO 
accumulates within the nucleus. 
 
To test whether Ca
2+ activation of nNOS is required for HDAC2 S-nitrosylation, human 
embryonic kidney 293 (HEK293) cells stably expressing nNOS were treated with the calcium 
ionophore A23187 (50nM).  Cell lysates were subjected to the biotin-switch assay, followed by 
precipitation with streptavidin and HDAC2 western blotting.  I observed that S-nitrosylation of 
HDAC2  was  induced  by  calcium  signalling,  suggesting  that  calcium-dependent  activation  of 
nNOS provides an endogenous source of NO (Fig. 3.1).  As a negative control, S-nitrosylation of 
HDAC2  was  analysed  in  E14.5  cortical  cultures  from  nNOS  null  mice  (Huang  et  al  1993).  
Embryonic  cortical  cultures  obtained  from  both  nNOS  null  and  wild-type  littermates  were 
exposed to BDNF (75ng/ml) and A23187 (50nM).  Cell lysates were subjected to the biotin-
switch  assay,  followed  by  precipitation  with  streptavidin  and  detection  by  HDAC2  western   68 
blotting.    While  both  BDNF  and  A23187  induced  S-nitrosylation  of  HDAC2  in  wild-type 
cultures, HDAC2 S-nitrosylation was completely absent in nNOS null cultures exposed to the 
same stimuli (Fig. 3.2).  This data indicates that HDAC2 nitrosylation requires both BDNF and 
calcium signalling, suggesting that nNOS activation is the major source of NO synthesis under 
these conditions.  HDAC2 has recently been implicated in cell fate determination of progenitor 
cells (Shaked et al 2008) and NO has been shown to modulate the ability of cortical precursors to 
differentiate into mature neurons however, the molecular targets of NO have yet to be elucidated 
(Packer  et  al  2003;  Matarredona  et  al  2004;  Moreno-Lopez  et  al  2004).    Nitrosylation  of  a 
chromatin-remodelling  protein  provides  a  direct  mechanism  whereby  NO  regulates  the 
transcriptional profile of progenitor cells to define their cell fate. 
 
HDAC2 is a 55KDa protein containing ten cysteine residues that are conserved between 
human, rat and mouse species (Fig. 3.3).  The primary sequence of HDAC2 does not contain any 
obvious acid-base consensus motifs associated with cysteine nitrosylation.  Hydrophobicity plots 
show the distribution of polar and non-polar residues along the protein sequence and are used to 
predict  hydrophobic  regions.    Although  the  hydrophobicity  plot  of  HDAC2  did  not  reveal 
cysteine residues within hydrophobic regions, S-nitrosylation consensus motifs or hydrophobic 
pockets might be hidden in the tertiary structure of HDAC2, making them difficult to predict.  
Unfortunately, the tertiary structure of HDAC2, and its closest relative HDAC1, remains to be 
determined. 
 
Cysteine  residue  152  (Cys152)  is  highly  conserved  between  class  I  HDACs,  and  has 
previously been implicated in the synthesis of acetate, the by-product of lysine deacetylation   69 
(Vannini et al 2004) (Fig. 3.3).  Nitrosylation of Cys152 could result in conformational changes 
that  prevent  acetate  formation,  thus  inhibiting  the  deacetylase  activity  of  HDAC2.    To  test 
whether Cys152 was S-nitrosylated, I mutated this cysteine residue to an alanine (HDAC2
C152A).  
Alanine residues do not possess the thiol group targeted by nitrosylation, therefore if Cys152 was 
the residue targeted by NO, exposure of HDAC2
C152A to NO donors should not result in HDAC2 
nitrosylation.  HDAC2
C152A was expressed in HEK293 cells and cell lysates were exposed to the 
NO donor S-nitrosocysteine (SNOC; 200µM for 30 minutes).  Lysates containing HDAC2
C152A 
were subjected to the biotin-switch assay followed by precipitation with streptavidin and HDAC2 
western  blotting.    I  observed  that  exposure  to  SNOC  induced  HDAC2
C152A  nitrosylation, 
indicating  that  NO  must  target  a  different  cysteine  residue  (data  not  shown).    I  generated 
expression vectors containing HDAC2 bearing a single mutation of each cysteine residue and 
subjected them to the biotin-switch assay.  I found that all single mutations of HDAC2 were 
nitrosylated upon exposure to NO donors (Fig 3.3, data not shown), suggesting that HDAC2 was 
nitrosylated  on  multiple  cysteine  residues.    S-nitrosylation  of  proteins  on  multiple  cysteine 
residues is not uncommon and has been observed for a number of proteins, including GAPDH, 
NMDAR and eNOS (Molina et al 1992; Takahashi et al 2007; Tummala et al 2008). 
 
I next performed further structure to function analysis to assess which cysteine residues 
were targeted by NO.  I was able to exclude 7 cysteine residues as potential targets of NO by 
exposing truncated forms of HDAC2 to NO donors and testing for nitrosylated cysteines (Fig. 
3.4).    Six  constructs  containing  N-terminal  and  C-terminal  truncated  forms  of  Myc-tagged 
HDAC2 were generated.  The constructs were expressed in HEK293T cells and lysates were 
exposed to SNOC (200µM for 30 minutes) and subjected to the biotin-switch assay followed by   70 
streptavidin  precipitation  and  Myc  western  blotting.    I  observed  that  HDAC2  constructs 
containing  amino  acids  1-261  and  286-488  were  consistently  not  nitrosylated  (Fig  3.4,  3.5), 
indicating that Cys262, Cys274 and Cys285 were possible targets of NO.  I next generated three 
constructs  containing  HDAC2  with  only  two  of  these  cysteine  residues  mutated  to  alanine, 
HDAC2
C262A/C274A, HDAC2
C262A/C285A and HDAC2
C274A/C285A.  The constructs were expressed in 
HEK293T cells and lysates were exposed to SNOC and subjected to the biotin-switch assay 
followed by streptavidin precipitation and HDAC2 western blotting.  I observed that constructs 
containing  HDAC2  with  single  mutations  of  Cys262  or  Cys274  were  nitrosylated  following 
exposure to NO donors while HDAC2
C262A/C274A was not nitrosylated (Fig. 3.6).  These results 
demonstrate that Cys262 and Cys274 of HDAC2 are the residues targeted by NO. 
 
To  test  whether  Cys262  and  Cys274  were  S-nitrosylated  in  neurotrophin-stimulated 
neurons, embryonic cortical cultures were transfected with vectors encoding either HDAC2
WT or 
HDAC2
C262A/C274A and exposed to BDNF (75ng/ml) for 30 minutes.  Cell lysates were subjected 
to the biotin-switch assay followed by streptavidin precipitation and HDAC2 western blotting.  
Although the transfection efficiency of cortical neurons was less than 10%, the biotin-switch 
assay was sensitive enough to allow the detection of nitrosylated HDAC2
WT (Fig. 3.7).  I was 
able to detect intracellular nitrosylation of HDAC2
WT expressed in embryonic cortical neurons.  
Importantly, I did not detect S-nitrosylation of HDAC2
C262A/C274A in cortical neurons exposed to 
the same stimulus.  These results indicate that Cys262 and Cys274 are the cysteine residues 
nitrosylated in neurons in response to neurotrophin stimulation. 
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In  summary,  BDNF  stimulation  of  cortical  neurons  induces  nNOS  activation  and 
accumulation of NO within the nucleus.  Nuclear NO induces nitrosylation of various nuclear 
proteins,  including  the  chromatin  remodelling  protein  HDAC2.    Previous  studies  have 
demonstrated that BDNF and NO are important regulators of proliferation and differentiation of 
neuronal progenitor cells (Barnabe-Heider and Miller 2003; Cheng et al 2003; Packer et al 2003; 
Moreno-Lopez  et  al  2004;  Bartkowska  et  al  2007)  and  are  capable  of  generating  profound 
changes in gene expression (Hemish et al 2003; Dhakshinamoorthy et al 2007).  Modulation of 
HDAC2 function through S-nitrosylation may provide an intriguing link between BDNF and NO-
dependent regulation of gene expression in neurons.   72 
Figure  3.1  Endogenous  HDAC2  is  S-nitrosylated  in  embryonic  cortical  neurons  upon 
neurotrophin stimulation.  Cultured cortical neurons were treated with BDNF (75ng/ml for the 
indicated times) and GSNO (100µM, 30 min).  HEK 293 cells expressing nNOS were treated 
with A23187 (50µM, 20 min) and GSNO (10µM, 30 min).  Cultures were subject to the biotin-
switch assay followed by streptavidin precipitation and HDAC2 western blotting.  Equal loading 
prior to streptavidin precipitation was assessed by HDAC2 western blotting (lower panel); n=3. 
 
Figure 3.2 BDNF-dependent HDAC2 S-nitrosylation is absent in cortical neurons obtained 
from nNOS null mice.  Embryonic cortical cultures from wild-type and nNOS null mice were 
treated with BDNF (75ng/ml, 30 mins), A23187 (50µM, 20 min) or vehicle (Ctrl) and subjected 
to the biotin-switch assay, followed by streptavidin precipitation and HDAC2 western blotting. 
Equal loading prior to streptavidin precipitation was assessed by HDAC2 western blotting (lower 
panel); n=3. 
 
Figure  3.3  HDAC2  is  highly  conserved  between  mammalian  species.    An  amino  acid 
sequence alignment of mouse, rat and human HDAC2 using ClustalW2 (Larkin et al 2007).  Blue 
text indicates Asp178, His180 and Asp267 that are predicted to coordinate with the catalytic zinc 
ion.  Blue arrows indicate additional catalytic residues.  Red text indicates conserved HDAC2 
cysteine residues and nitrosylated Cys262 and Cys274 are marked by red boxes. 
 
Figure  3.4  Schematic  representations  of  truncated  forms  of  HDAC2.    A  series  of  N-
terminal and C-terminal truncations of HDAC2 were generated (labelled D1-D6).  Nitrosylation 
was detected when the HDAC2 truncations, D1, D2, D5 and D6 (yellow), were exposed to NO   73 
donors.  The two HDAC2 truncations, D3 and D4 (red), were not nitrosylated in the presence of 
NO donors. 
 
Figure 3.5 Cys262 and Cys274 of HDAC2 are S-nitrosylated.  Myc-tagged N-terminal and 
C-terminal  truncations  (D1,  D3  &  D5)  and  full-length  HDAC2  (WT)  were  expressed  in 
HEK293T cells and exposed to SNOC (200µM, 30 min) or vehicle (Ctrl).  Lysates were subject 
to the biotin-switch assay, followed by streptavidin precipitation and Myc western blotting (top 
panel).  Equal loading prior to streptavidin precipitation was assessed by Myc western blotting 
(lower panel); n=3. 
 
Figure  3.6  Cys262  and  Cys274  of  HDAC2  are  S-nitrosylated.    Flag-tagged  mutants, 
HDAC2
C262A,  HDAC2
C274A,  HDAC2
C262A/C274A,  wild-type  HDAC2
WT  and  empty  vector  (EV) 
were expressed in HEK293T cells.  Lysates were exposed to SNOC (200µM, 30 min) or vehicle 
and subject to the biotin-switch assay, followed by streptavidin precipitation and HDAC2 western 
blotting  (top  panel).    Equal  loading  prior  to  precipitation  with  streptavidin  was  assessed  by 
HDAC2 and Flag western blots (lower panels); n=3. 
 
Figure 3.7 Neurotrophin stimulation of cortical neurons induces nitrosylation of Cys262 
and Cys274 of HDAC2.  Embryonic cortical neurons expressing Flag-tagged HDAC2
C262A/C274A, 
HDAC2
WT and EV were exposed to SNOC (200µM, 30 min) and subject to biotin-switch assay, 
followed by streptavidin precipitation and HDAC2 western blotting (top panel). Equal loading 
prior to precipitation with streptavidin was assessed by HDAC2 and Flag western blotting (lower 
panels); n=3, Flag-HDAC2, Flag-tagged HDAC2; End-HDAC2, Endogenous HDAC2. 0’
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74Fig. 3.3
                                                                                       
                                                                                       
mHDAC2 --------------------------------------------------------------------------------          0
rHDAC2 MVISYHKLSRNKPSSLFPDIFKSGSGDLCFPLRAAAVVPPNSQPRRPEAYPCRVSRVGAAANPALRSRALPAPARRPAPG         80
hHDAC2 FG-----------GPLLAS--------WC---------------------RCHL-RFRAFGTSAGWYRAFPAPPPLLPPA         39
                                                       ---------+---------+---------+--
                                                                10        20        30 
                                                       ---------+---------+---------+--
mHDAC2 ------------------------------------------------MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMK         32
rHDAC2 CPCCEGRRARRLPQPSCLAAGPRRARAAGGGAAARRRRP-------EPMAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMK        153
hHDAC2 CPSPRDYRPH-VSLSHFLS---RPSRGGSSSSSSSRRRSPVAAVAGEPMAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMK        115
       -------+---------+---------+---------+---------+---------+---------+---------+--
              40        50        60        70        80        90        100       110
       -------+---------+---------+---------+---------+---------+---------+---------+--
mHDAC2 PHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQ        112
rHDAC2 PHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQ        233
hHDAC2 PHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQ        195
       -------+---------+---------+---------+---------+---------+---------+---------+--
              120       130       140       150       160       170       180       190
       -------+---------+---------+---------+---------+---------+---------+---------+--
mHDAC2 LSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTD        192
rHDAC2 LSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAVLELLKYHQRVLYIDIDIHHGDGVEEAFYTTD        313
hHDAC2 LSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTD        275
       -------+---------+---------+---------+---------+---------+---------+---------+--
              200       210       220       230       240       250       260       270
       -------+---------+---------+---------+---------+---------+---------+---------+--
mHDAC2 RVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRL        272
rHDAC2 RVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRL        393
hHDAC2 RVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRL        355
       -------+---------+---------+---------+---------+---------+---------+---------+--
              280       290       300       310       320       330       340       350
       -------+---------+---------+---------+---------+---------+---------+---------+--
mHDAC2 GCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMT        352
rHDAC2 GCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMT        473
hHDAC2 GCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTHETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMT        435
       -------+---------+---------+---------+---------+---------+---------+---------+--
              360       370       380       390       400       410       420       430
       -------+---------+---------+---------+---------+---------+---------+---------+--
mHDAC2 NQNTPEYMEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEEFSDSEDEGEGGR        432
rHDAC2 NQNTPEYMEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEEFSDSEDEGEGGR        553
hHDAC2 NQNTPEYMEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEEFSDSEDEGEGGR        515
       -------+---------+---------+---------+---------+--------
              440       450       460       470       480      
       -------+---------+---------+---------+---------+--------
mHDAC2 RNVADHKKGAKKARIEEDKKETEDKKTDVKEEDKSKDNSGEKTDPKGAKSEQLSNP                                488
rHDAC2 RNVADHKKGAKKARIEEDKKEAEDKRTDVKEEDKSKDNSGEKTDTKGAKSEQLNNP                                609
hHDAC2 RNVADHKKGAKKARIEEDKKETEDKKTDVKEEDKSKDNSGEKTDTKGTKSEQLSNP                                571
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Chapter 4  HDAC2
C262A/C274A strongly associates with chromatin 
 
S-nitrosylation of HDAC2 may affect its function by either modulating its catalytic activity 
or by affecting its localisation.  Crystal structures have been determined for human HDAC8 and 
Aquifex aeolicus HDAC-like protein (HDLP), which share 41% and 35% sequence homology 
with HDAC2, respectively (Finnin et al 1999; Vannini et al 2004; Somoza et al 2004).  The 
deacetylase  core  consists  of  a  narrow  12Å-deep  pocket  lined  with  hydrophobic  residues 
conserved between all class I HDACs.  The bottom of the pocket contains a Zn
2+ ion essential for 
the deacetylase activity, which is coordinated by Asp178, His180 and Asp267 (Fig. 4.1).  The 
crystal  structure  of  HDAC8  reveals  that  two  conserved  residues,  Arg-37  and  Cys153,  are 
necessary for the synthesis of acetate, the by-product of lysine deacetylation (Fig. 4.1) (Vannini 
et al 2004).  The hydroxamic acid inhibitor used to generate HDAC8 crystals was bound to 
His142, His143 and Tyr306 (Vannini et al 2004).  These residues are highly conserved between 
class I HDACs and are likely to be involved in HDAC catalysis.  A predicted tertiary structure of 
HDAC2 based on crystallography data of HDAC8 revealed that nitrosylated Cys262 and Cys274 
should not interfere stochiometrically with amino acid residues essential for Zn
2+ coordination 
and deacetylase activity (Fig. 4.1) (Vannini et al 2004; Somoza et al 2004).  Cys262 is buried 
within a hydrophobic tunnel, whereas Cys274 is located at the protein surface (Fig. 4.1).  The 
location of Cys262 and Cys274 away from the active site residues suggests that S-nitrosylation of 
HDAC2 may have little effect on its deacetylase activity.  Furthermore, NO has been previously 
demonstrated to regulate HDAC4 and HDAC5 independent of their catalytic activity through 
modulation of subcellular localisation (Illi et al 2008).  NO may regulate HDAC2 function by 
modulating its affinity for certain repressive complexes, thereby determining its association with   79 
specific gene promoters.  However, the possibility remains that a post-translational modification 
such as S-nitrosylation may cause dramatic conformational changes that could possibly impair or 
enhance HDAC2 deacetylase activity. 
 
To determine whether BDNF-dependent nitrosylation of HDAC2 influences its activity, a 
fluorometric HDAC activity assay was employed in collaboration with Dr P. Marc Watson.  The 
HDAC activity assay is dependent on a non-fluorogenic peptide BOC-(acetyl)lys-AMC, which 
upon deacetylation becomes  susceptible to trypsin digestion, generating a fluorogenic moiety 
detected  at  excitation/emission  maxima  of  360/460nm.    Experiments  were  performed  by 
immunoprecipitating HDAC2 followed by incubation with BOC-(acetyl)lys-AMC for 1 hour at 
37
oC,  during  which  deacetylation  occurs.    The reaction  was  then  quenched  using  the  potent 
HDAC  inhibitor  trichostatin  A (TSA), followed  by  a  short  incubation  with  trypsin.    To  test 
whether  either  neurotrophin  or  NO  signalling  affected  the  catalytic  activity  of  HDAC2, 
embryonic cortical cultures were treated with BNDF (75ng/ml) or SNOC (200µM).  Cell lysates 
were  immunoprecipitated  using  a  HDAC2  antibody  and  analysed  by  performing  the  HDAC 
activity  assay.    We  observed  that  neither  BDNF  nor  NO  stimulation  of  cortical  neurons 
influenced the catalytic activity of endogenous HDAC2 (Fig. 4.2).  These data indicate that NO 
regulates HDAC2 function independently of its deacetylase activity. However, S-nitrosylation of 
HDAC2  may  cause  conformational  changes  that  prevents  or  enhances  its  association  within 
activating or repressive complexes. 
 
To investigate further whether NO signalling regulates HDAC2 function I employed Flag-
tagged  HDAC2
WT  and  HDAC2
C262A/C274A  constructs.    Functional  analysis  requires  that  Flag-  80 
tagged HDAC2 constructs retain their endogenous deacetylase activity.  PC12 cells expressing 
either  HDAC2
WT  or  HDAC2
C262A/C274A  were  exposed  to  NGF  (100ng/ml),  SNOC  (200M)  or 
vehicle.  Cell lysates were immunoprecipitated using a Flag antibody, and subjected to HDAC 
activity  assay.    As  expected,  NGF  and  NO  donors  had  no  affect  on  HDAC2
WT  and 
HDAC2
C262A/C274A  enzymatic  activity,  when  compared  to  unstimulated  cultures  (Fig.  4.3).  
However, we observed that the deacetylase activity of HDAC2
C262A/C274A was somewhat lower 
than HDAC2
WT (Fig. 4.3).  This may be due to the fact that cysteine residues frequently form 
disulphide bridges, which is a covalent bond that occurs when two cysteine residues oxidise 
together.  Formation of disulphide bonds is often associated  with the stabilization of protein 
tertiary structure.  The absence of two cysteine residues in HDAC2
C262A/C274A may make it more 
susceptible to protein unfolding and protease-mediated degradation.  The HDAC activity assay is 
based  on  a  protocol  that  includes  a  1  hour  incubation  step  at  37
oC.   This  may  increase  the 
susceptibility of HDAC2
C262A/C274A to degradation by proteases released during cell lysis.  Protein 
degradation was minimised by decreasing the duration of immunoprecipitation from overnight to 
2 hours, which resulted in reduced degradation of HDAC2
C262A/C274A.  Moreover, when protease 
inhibitors  were  included  during  the  37
oC  incubation,  degradation  of  HDAC2
C262A/C274A  was 
further reduced.  In summary, I observed that neurotrophin-dependent S-nitrosylation of HDAC2 
does  not  influence  its  enzymatic  activity.    S-nitrosylation  has  been  demonstrated  to  regulate 
protein functions by modulating protein-protein interactions.  For example, S-nitrosylation of N-
ethylmaleimide sensitive factor (NSF) enhances its binding to GluR2 receptors, which increases 
cell  surface  localisation  of  AMPA  receptors  (Huang  et  al  2005).    The  finding  that  HDAC2 
activity is unaffected by NO signalling led us to investigate whether S-nitrosylation of HDAC2   81 
may affect its ability to bind specific corepressors, thereby dictating its association with gene 
promoters.   
 
To  test  whether  S-nitrosylation  of  HDAC2  influences  its  localisation  at  specific  gene 
promoters, the Chromatin ImmunoPrecipitation (ChIP) technique was employed in collaboration 
with Dr Antonella Riccio.  This is a powerful technique that allows the detection of proteins 
bound to DNA, such as histones, or proteins associated with DNA, such as repressive/activating 
complexes and proteins within the transcriptional machinery.  Proteins are cross-linked to DNA 
using formaldehyde, followed by cell lysis and sonication to shear the genomic DNA.  Proteins 
cross-linked to DNA are immunoprecipitated using an appropriate antibody.  Cross-linking of 
immunoprecipitated DNA-protein complexes is reversed and the DNA is purified.  The presence 
of immunoprecipitated proteins on specific promoters can be detected by quantitative Polymerase 
Chain  Reaction  (qPCR)  analysis.    Previous  ChIP  experiments  have  demonstrated  that 
endogenous HDAC2 is bound to the Fos promoter in unstimulated embryonic cortical cultures 
(Riccio et al 2006).  Treatment of cortical cultures with BDNF leads to the release of HDAC2 
from the Fos promoter (Riccio et al 2006).  BDNF-stimulated release of HDAC2 from the Fos 
promoter can be blocked using NOS inhibitors (Riccio et al 2006) suggesting that neurotrophins 
regulate HDAC2 DNA binding through a NO-dependent mechanism. 
 
To study whether nitrosylation of HDAC2 influences its association with DNA, PC12 cells 
were transfected with either Flag-tagged HDAC2
WT or HDAC2
C262A/C274A constructs and exposed 
to  NGF  (50ng/ml),  SNOC  (200µM)  or  vehicle.    ChIP  assays  were  performed  by 
immunoprecipitating cell lysates with a Flag antibody followed by qPCR of gene promoters.  I   82 
choose  to  analyse  CREB-regulated  gene  promoters  that  are  activated  following  neurotrophin 
stimulation and NO signalling in cortical neurons (Riccio et al 2006).  Treatment with either NGF 
or SNOC led to a 5-fold reduction in HDAC2
WT occupancy at the Fos promoter when compared 
to  unstimulated  cells  (Fig.  4.3,  4.4),  confirming  that  neurotrophin–dependent  NO  signalling 
modulates the association of HDAC2 with DNA.  In contrast both NGF and SNOC did not affect 
the association of HDAC2
C262A/C274A with the Fos promoter (Fig. 4.4, 4.5) demonstrating that 
nitrosylation of HDAC2 on Cys262 and Cys274 is necessary for the release of HDAC2 from 
DNA. 
 
To test whether NO regulates HDAC2 binding at multiple gene promoters, we performed 
ChIP  analysis  of  Egr1,  Vgf  and  Nos1  promoters.    Neurotrophin  and  NO  treatment  strongly 
reduced the binding of HDAC2
WT to Egr1, Vgf and Nos1 promoters, while HDAC2
C262A/C274A 
binding to the same promoters was not affected by either NGF or NO stimulation (Fig. 4.6).  
These  data  demonstrates  that  nitrosylation  of  HDAC2  following  neurotrophin  stimulation 
influences HDAC2 binding to multiple gene promoters. 
 
Many  neuronal  genes  contain  a  conserved  RE1  motif  that  binds  to  the  transcriptional 
repressor,  REST.    Neuronal  genes  of  progenitor  cells  are  silenced  by  the  recruitment  of 
Sin3A/HDAC complexes following REST binding.  An intriguing possibility is that nitrosylation 
of  HDAC2  disrupts  its  interaction  with  the  REST  complex.    This  would  result  in  a  loss  of 
HDAC2  from  neuronal  gene  promoters,  followed  by  increased  histone  acetylation  and  gene 
activation.   83 
Figure 4.1 Predicted tertiary model of HDAC2.  A predicted tertiary structure of HDAC2 
based on crystallography data of HDAC8 using Swiss – PdbViewer software.  Helical structures 
are highlighted in green and β-strands in blue.  Cys262 and Cys274 are labelled in red.  Asp177, 
His179 and Asp265, which are known to coordinate with Zn
2+, are labelled in yellow. 
 
Figure 4.2 Endogenous HDAC2 deacetylase activity is unaffected by neurotrophin or NO 
stimulation of cortical neurons.  Embryonic cortical neurons were exposed to BDNF (75ng/ml, 
20 min), SNOC (200µM, 20 min), TSA (1 µM, 20 min) or vehicle (Ctrl), and subjected to 
HDAC2 immunoprecipitation followed by HDAC activity fluorometric assay.  As a negative 
control, the HDAC activity assay was performed on lysates immunoprecipitated with normal 
IgG.  Data is presented as average fold change of fluorescence over IgG control; n=3 (upper 
panel).    Equal  loading  was  assessed  by  HDAC2  western  blotting  of  lysates  before 
(immunoprecipitation) or after (input) immunoprecipitation. 
 
Figure  4.3  NGF  and  NO  stimulation  do  not  change  deacetylase  activity  of 
HDAC2
C262A/C274A  and  HDAC2
WT.    PC12  cells  expressing  N-terminal  Flag-tagged  HDAC2
WT, 
HDAC2
C262A/C274A or an EV control were treated with NGF (100ng/ml, 20 min), SNOC (200µM, 
20 min) or vehicle (Ctrl), and subjected to Flag immunoprecipitation followed by HDAC activity 
fluorometric assay.  Data is presented as an average of arbitrary units +/- SEM; n=3.  Equal 
loading was assessed by Flag western blot (lower panel). 
 
Figure 4.4 HDAC2
C262A/C274A is strongly associated with the Fos promoter.  PC12 cells 
expressing HDAC2
WT, HDAC2
C262A/C274A or EV control were treated with NGF (100ng/ml, 20   84 
min),  SNOC  (200µM,  20  min)  or  vehicle  (Ctrl)  and  subject  to  ChIP  assay.    Lysates  were 
immunoprecipitated with Flag antibody and analysed by qPCR for the Fos promoter; n=3.  PI, 
immunoprecipitation with pre-immune serum. 
 
Figure 4.5 HDAC2
C262A/C274A is strongly associated with multiple CREB-regulated gene 
promoters.  PC12 cells expressing HDAC2
WT, HDAC2
C262A/C274A or EV control were treated with 
NGF (100ng/ml, 20 min), SNOC (200 µM, 20 min) or vehicle (Ctrl).  Lysates were subjected to 
ChIP using Flag immunoprecipitation followed by qPCR for the indicated gene promoters.  Data 
is normalised to total input and represented as average fold change over vehicle control (Ctrl) +/- 
SEM; *P<0.05; **P<0.005; n=3. 
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Chapter  5    HDAC2
C262A/C274A  is  a  powerful  transcriptional 
repressor 
 
HDAC2 was initially characterised for its ability to remove acetyl groups from histone 
proteins (Rundlett et al 1996; Yang et al 1996).  Acetylation of histone H3 Lys9 and Lys14 
(H3K9/K14) is associated with gene activation in human embryonic stem cells (Pokholok et al 
2005; Guenther et al 2007).  Acetylation of histone H3K9/K14, together with the recruitment of 
RNA polymerase II is necessary for initiation of transcription and it is now widely recognized as 
a marker of transcriptionally active genes (Pokholok et al 2005; Guenther et al 2007).  To study 
whether S-nitrosylation of HDAC2 influenced histone acetylation, the ChIP assay was employed 
in  collaboration  with  Dr  Antonella  Riccio.    PC12  cells  expressing  either  HDAC2
WT  or 
HDAC2
C262A/C274A  or  empty  vector  (EV)  were  exposed  to  NGF,  SNOC  or  vehicle  and 
immunoprecipitated with pan-acetylated histone H4 (AcH4) or acetylated histone H3 K9/K14 
(AcH3K9/K14)  antibodies.    DNA  was  purified  from  immunoprecipitated  DNA-histone 
complexes  and  analysed  by  qPCR  for  various  gene  promoters.    Treatment  of  PC12  cells 
expressing HDAC2
WT with NGF and SNOC induced a robust increase in acetylation of histone 
H4 and H3 at the Fos, Egr1, Vgf and Nos1 promoters (Fig. 5.1).  In stark contrast, histone 
acetylation of these promoters remained unchanged in PC12 cells expressing HDAC2
C262A/C274A 
(Fig. 5.1).  These data indicate that nitrosylation of HDAC2 following neurotrophin and NO 
signalling increases acetylation of histones H3 and H4 at multiple gene promoters. 
 
Acetylation  levels  however,  varied  greatly  between  gene  promoters.    For  example, 
acetylation of histone H3 and H4 of Egr1 and Vgf, was induced 8-fold following NGF and SNOC   88 
treatment, compared to a 4-fold induction observed at the Fos promoter (Fig. 5.1).  In contrast, 
NGF and SNOC treatment resulted in little or no induction of histone H4 acetylation of the Nos1 
promoter (Fig. 5.1).  Acetylation of lysine residues on histone N-terminal tails is thought to 
reduce positive charges and decrease their association with negatively charged DNA (McGhee 
and  Felsenfeld  1980).    Histone  acetylation  is  associated  with  conformational  changes  in 
chromatin  structure  that  allows  the  binding  of  transcription  machinery  and  gene  activation.  
Differences  of  histone  acetylation  at  specific  residues  between  gene  promoters  may  reflect 
different modes of activation in response to neurotrophins.  An increase of AcH3K9/K14 has 
been demonstrated to strongly correlate with actively transcribed genes (Pokholok et al 2005; 
Guenther et al 2007).  Therefore, a rapid induction of H3 acetylation on K9/K14 may indicate 
rapid  activation  of  genes  that  were  previously  silent.   Exposure  of  neurons  to  neurotrophins 
rapidly induces the transcription of immediate early genes (Callela et al 2007).  This may explain 
the 8-fold induction of AcH3K9/K14 observed at the Egr1 promoter.  Transcriptional responses 
following acetylation of histone H4 are less well characterised, but may reflect activation of gene 
promoters  that  already  exhibit  a  basal  level  of  transcription,  which  may  explain  the  10-fold 
induction observed at the Vgf promoter. 
 
Alternatively, differences of histone acetylation may be a consequence of the primers used 
for the qPCR analysis.  Promoters are generally considered as a region of non-coding DNA 
situated  5’  of  the  initiation  site  that  contains  enhancer  elements  responsible  for  initiation  of 
transcription.  Gene promoters often span several kilobases, and may contain multiple enhancer 
elements that are differentially regulated.  Enhancer elements have also been located outside of 
promoter regions, including intronic sequences.  Acetylation of histones within gene promoters   89 
allows the binding of transcriptional activators to their respective enhancer elements.  However, 
different enhancers within the same promoter can be differentially regulated, which may reflect 
local  variations  of  histone  acetylation  at  gene  promoters.    The  ChIP  assay  requires  that  the 
genomic DNA is sheared into ~500 bp fragments, which results in immunoprecipitated protein-
DNA  complexes  that  contain  short  DNA  fragments.    qPCR  analysis  of  DNA,  purified from 
immunoprecipitated complexes, is performed using primers designed to amplify 300 base pair 
fragments or smaller.  Therefore, primers designed to loci slightly upstream or downstream of 
enhancer elements responsive to neurotrophin signalling may show lower acetylation levels. 
 
I  next  tested  whether  histone  acetylation  was  induced  in  PC12  cells  expressing 
HDAC2
C262A/C274A  following  neurotrophin  and  NO  stimulation.    PC12  cells  expressing 
HDAC2
C262A/C274A were stimulated with NGF (50ng/ml) and SNOC (200µM) and cell lysates 
were subjected to ChIP assay followed by qPCR analysis (Fig. 5.1).  I found that acetylation 
levels  of  Fos,  Egr1,  Vgf  and  Nos1  promoters  remained  low  when  PC12  cells,  expressing 
HDAC2
C262A/C274A, were treated with NGF and SNOC (Fig. 5.1).  Thus, nitrosylation of HDAC2 
is necessary for neurotrophin-dependent histone acetylation at multiple gene promoters.  It is 
conceivable  that  HDAC2
C262A/C274A  is  unable  to  dissociate  from  the  chromatin  and  remains 
strongly  bound  to  gene  promoters  regardless  of  stimulation  by  neurotrophins.    My  findings 
indicate  that  neurotrophin  signalling  induces  nitrosylation  of  HDAC2  and  subsequent 
dissociation of HDAC2 from gene promoters, which increases acetylation of histones. 
 
I  next  addressed  whether  neurotrophin-dependent  gene  transcription  is  mediated  by 
HDAC2  nitrosylation  by  employing  the  dual  luciferase  reporter  assay.    Embryonic  cortical   90 
neurons were co-transfected with a firefly-luciferase construct containing the Fos promoter (-41 
to -498) together with various HDAC2 constructs or empty Flag vector.  Activation of the Fos 
promoter results in transcription of a firefly-luciferase protein, which can be measured using a 
luminometer.  As control, neurons were co-transfected with a Renilla-luciferase construct driven 
by the thymidine-kinase promoter (TK-luciferase).  The level of transcription mediated by the 
thymidine-kinase  promoter  is  independent  of  neurotrophin  stimulation,  thereby  serving  as  an 
internal  control  for  transfection  efficiency.    Cortical  neurons  expressing  empty  vector  were 
exposed  to  BDNF  (75ng/ml,  6  hours)  and  subjected  to  the  dual  luciferase  assay.    BDNF 
stimulation of cortical neurons resulted in a 2-fold induction of Fos promoter activity.  Pre-
treatment  of  cultures  with  the  nNOS  inhibitor,  NPA  (300µM)  completely  inhibited  BDNF-
dependent  activation  of  Fos.    This  finding  supports  previous  evidences  that  neurotrophin-
dependent gene expression in cortical neurons requires nNOS activity (Riccio et al 2006). 
 
To test whether activation of the Fos promoter requires nitrosylation of HDAC2, cortical 
neurons were transfected with HDAC2
WT or HDAC2
C262A/C274A followed by BDNF stimulation 
and processed using the dual luciferase assay.  As expected, treatment with BDNF of cortical 
neurons  expressing  HDAC2
WT  induced  activation  of  the  Fos  promoter  (Fig.  5.2;  P>0.001).  
Treatment of cortical cultures with NPA completely abolished BDNF-dependent activation of 
Fos (Fig. 5.2).  To investigate whether BDNF-dependent nitrosylation of HDAC2 mediated Fos 
expression, cortical neurons expressing HDAC2
C262A, HDAC2
C274A or HDAC2
C262A/C274A were 
stimulated with BDNF (75ng/ml) and cell lysates were subjected to the dual luciferase assay.  
Activation  of  the  Fos  promoter  was  induced  following  stimulation  with  BNDF  in  neurons 
expressing  HDAC2
C262A  and  HDAC2
C274A  however,  expression  of  HDAC2
C262A/C274A  blocked   91 
BDNF-induced activation of the Fos promoter.  Thus, S-nitrosylation of HDAC2 at both Cys262 
and Cys274 is necessary for activation of the Fos gene promoter.  These data imply that BDNF-
induced activation of the Fos promoter requires that nitrosylated HDAC2 dissociates from gene 
promoters, thereby facilitating transcriptional initiation. 
 
I  next  tested  whether  HDAC2  nitrosylation  is  necessary  to  induce  the  expression  of 
neurotrophin-dependent endogenous genes by performing northern blot analysis of Fos, Egr1 and 
Vgf.    PC12  cells  were  transfected  with  HDAC2
WT,  HDAC2
C262A/C274A  or  empty  vector  and 
exposed to NGF for 30, 60 and 180 minutes.  Total cellular mRNA was run on a denaturing 
agarose gel and transferred onto a nylon membrane.  The presence of RNA for specific genes was 
detected using a 
32P labelled complementary DNA probe.  An increase of RNA upon treatment 
with  NGF  indicates  an  initiation  in  gene  transcription  that  is  dependent  on  neurotrophin 
stimulation.  I observed that endogenous expression of Fos, Egr1 and Vgf was induced upon NGF 
treatment of PC12 cells expressing either en empty vector or a vector containing HDAC2
WT (Fig. 
5.3).  In contrast, the expression of all three genes following NGF stimulation was reduced in 
PC12 cells expressing HDAC2
C262A/C274A (Fig. 5.3).  These data indicate that HDAC2 is a key 
target of NO signalling following neurotrophin stimulation and confirms that HDAC2
C262A/C274A 
is a strong transcriptional repressor. 
 
The  development  of  the  cortex  depends  on  progenitor  cells  switching  from  a  highly 
proliferative state into mature post-mitotic neurons.  This dramatic change in cellular identity 
requires  long-lasting  changes  in  expression  of  multiple  genes.    I  have  demonstrated  that 
neurotrophin-dependent  S-nitrosylation  of  HDAC2  induces  histone  acetylation  in  embryonic   92 
cortical neurons and increases the expression of multiple genes.  Neurotrophin modulation of 
HDAC2 through NO signalling may provide an epigenetic mechanism by which the temporal 
activation of multiple neural genes can be tightly regulated during development.   93 
Figure 5.1 Nitrosylation of HDAC2 modulates histone acetylation.  PC12 cells expressing 
HDAC2
WT, HDAC2
C262A/C274A or EV control were treated with NGF (100ng/ml, 20 min), SNOC 
(200 µM, 20 min) or vehicle (Ctrl).  Lysates were subjected to ChIP analysis using either pan-
acetylated  histone  H4  (AcH4)  or  K9/K14-acetylated  histone  H3  (AcH3K9/K14).  
Immunoprecipitation was followed by qPCR analysis of promoter regions of Fos, Egr1, Vgf and 
Nos1.  Data is normalised to total input and represented as average fold change over vehicle 
control (Ctrl) +/- SEM; *P<0.005; n=3. 
 
Figure  5.2  Nitrosylation  of  HDAC2  regulates  Fos  expression  in  cortical  neurons.  
Embryonic cortical neurons co-expressing HDAC2 vectors (as indicated), Fos-luciferase vector 
(firefly) and TK-luciferase vector (Renilla) were treated with either BDNF, (75ng/ml), SNOC 
(200µM), NPA (300 µM), BDNF plus NPA, or vehicle (Ctrl) for 6 hours and subjected to dual 
luciferase reporter assay (Promega).  Raw values were normalised by TK-luciferase expression.  
Data is presented as fold induction over control Fos-luciferase expression, +/- SEM; *P<0.001; 
n=4.  EV is empty vector control. 
 
Figure 5.3 Nitrosylation of HDAC2 regulates the expression of multiple endogenous genes.  
PC12  cells  expressing  HDAC2
WT,  HDAC2
C262A/C274A  or  EV  control  were  treated  with  NGF 
(100ng/ml) for the indicated times and subjected to Northern blot analysis for Egr1, Vgf, Fos and 
Gapdh mRNA; n=3. 
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Chapter  6    Implications  of  HDAC2  S-nitrosylation  for  the 
development of cortical neurons in vivo and in vitro 
 
The development of the cortex is associated with progenitor cell differentiation and their 
migration  from  the  VZ  to  distinctive  layers  within  the  cortical  plate  (Fig.  6.1).    Cortical 
neurogenesis is characterised by a tight regulation of cell proliferation and differentiation which 
is  mediated  by  extrinsic  signals,  including  Notch,  ephrins  and  neurotrophins,  and  intrinsic 
effectors, such as chromatin remodelling factors (Barnabe-Heider and Miller 2003; Ito et al 2003; 
Cheng et al 2003; Ciani et al 2004).  In vivo neurogenesis of cells within the SVZ is enhanced in 
adult  nNOS  null  mice  (Packer  et  al  2003)  whereas  neurogenesis  is  decreased  in  mice  over-
expressing nNOS within the cortex, hippocampus and striatum (Packer et al 2005).  Notably, 
TrkB deletion in pyramidal cells during development leads to the compression of cortical layers 
II/III and V, suggesting that BDNF signalling is critical for neocortical development (Xu et al 
2000).  We have shown that neurotrophin stimulation of cortical neurons induces S-nitrosylation 
of the nuclear protein HDAC2, which results in transcriptional activation of multiple genes.  This 
provides  a  mechanism  whereby  neurotrophin-induced  NO  signalling  influences  cell 
differentiation and migration during cortical development. 
 
To test whether activity-dependent S-nitrosylation of HDAC2 affects neuronal development 
in vitro, embryonic cortical neurons were co-transfected with green fluorescent protein (GFP) and 
either HDAC2
WT, HDAC2
C262A/C274A or empty vector.  I observed that average dendritic lengths 
of  neurons  transfected  with  HDAC2
C262A/C274A  were  significantly  shorter  when  compared  to 
neurons expressing HDAC2
WT or empty vector (Fig. 6.2, 6.3).  Stimulation of cortical neurons   97 
with  KCl  leads  to  neuronal  depolarisation  and  increases  intracellular  calcium.    It  has  been 
previously  demonstrated  that  exposure  of  cortical  neurons  to  KCl  (50mM)  greatly  enhances 
dendritic growth (Redmond et al 2000; Redmond et al 2002).  Neurons transfected with either 
HDAC2
WT or empty vector and exposed to KCl for 48 hours showed increased average dendritic 
length of almost 50 µm (Fig. 6.2, 6.3).  Importantly, expression of HDAC2
C262A/C274A completely 
blocked an activity-dependent increase in dendritic length (Fig. 6.2, 6.3).  These findings strongly 
support the hypothesis that HDAC2 nitrosylation mediates the expression of genes necessary for 
dendritic projection during development.   
 
To ascertain whether NO inhibition of HDAC2 influences cortical development in vivo, I 
employed an ex vivo electroporation technique (Fig. 6.4).  Development of the neocortex requires 
the generation of a diverse range of neuronal subtypes characterized by the expression of distinct 
genes.    Migration  of  neuronal  subtypes  is  restricted  to  specific  cortical  layers  where  precise 
connections with a subset of target cells are established.  The generation of neuronal subtypes and 
subsequent migration to specific layers follows a tightly regulated temporal pattern (Fig. 6.1).  
The first post-mitotic neurons migrate radially from the VZ at E11, forming the pre-plate at the 
pial surface of the brain.  The preplate is split into a marginal zone and a deeper subplate by a 
second  wave  of  postmitotic  neurons  migrating  from  the  VZ  at  E13.    Postmitotic  neurons 
generated between E14 and E18, leave the VZ at distinct phases and migrate radially to the 
marginal zone, passing previously established cortical layers to form an ‘inside out’ patterning of 
the cortical plate.  Once the layering of the cortex has been established, the subplate degenerates, 
establishing the six-layered neocortex found in the adult brain. 
   98 
Cortical pyramidal neurons are generated from asymmetric division of radial glial cells, 
with  the  generation  of  an  additional  self-renewal  progenitor  cell.    Radial  glial  cells  produce 
intermediate neuronal precursors that retain a limited proliferative capability.  Neuronal precursor 
cells undergo two further cell divisions within the SVZ and IZ to produce four multi-polar early 
neurons  that  migrate  radially  into  the  cortical  plate.    Generation  of  intermediate  neuronal 
precursors allows a rapid increase of pyramidal neurons from a small number of radial glial cells 
and is thought to be essential for the expansion of the cortical plate during development. 
 
The ex vivo electroporation technique involves the microinjection of DNA within the lateral 
ventricles of the whole brain, followed by electroporation of progenitor cells along the VZ (Fig. 
6.4).  Mouse brains were electroporated with a modified pCIG2 construct containing an HDAC2-
IRES-eGFP expression cassette under the control of a cytomegalovirus (CMV) enhancer and a 
chicken ß-actin promoter (Hand et al 2005).  This promoter cassette allows the expression of 
HDAC2  and  eGFP  within  undifferentiated  cortical  progenitor  cells.    Coronal  sections  of 
electroporated E14.5 mouse brains were cultured on semi-permeable organotypic membranes for 
5 days (Fig. 6.4).  Immuno-staining of eGFP allowed the identification of HDAC2 transfected 
cells and the analysis of their migration path from the VZ.  Cortical morphology was visualised 
by immuno-staining for nestin-positive radial glial cells.  Preliminary data suggests that E14.5 
cortical  progenitors  expressing  HDAC2
C262A/C274A  exhibit  impaired  radial  migration  into  the 
cortical plate, when compared to cells transfected with either HDAC2
WT or empty vector (Fig. 
6.5).  This implies that gene activation following nitrosylation of HDAC2 is necessary for normal 
radial migration of cortical precursor cells and corroborates an early study that observed impaired 
migration of granule cells in brain slices cultured in the presence of NOS inhibitors (Tanaka et al   99 
1994).    Similarly,  radial  migration  of  cortical  progenitors  was  impaired  following  in  utero 
electroporation of a dominant-negative TrkB construct or SirTrkB oligonucleotides (Bartkowska 
et al 2007).  I have demonstrated that BDNF induces S-nitrosylation of HDAC2 and dissociation 
of HDAC2 from specific gene promoters.  Disruption of HDAC2 S-nitrosylation through site-
directed mutagenesis of two specific cysteine residues impairs the radial migration of cortical 
precursors.  Possible implications of the ex vivo data is that S-nitrosylation of HDAC2 following 
stimulation with BDNF is necessary for the normal layering of the cortex. 
 
The  lack  of  cells  expressing  HDAC2
C262A/C274A  within  the  cortical  plate  may  be  a 
consequence of either increased apoptosis or impaired neurogenesis and migration.  To determine 
whether  HDAC2
C262A/C274A  influences  apoptosis,  transfected  cortical  slices  will  be  immuno-
stained using an antibody raised against cleaved caspase-3.  Cleavage of immature pro-caspases 
leads  to  activation  of  apoptotic  pathways  and  subsequent  DNA  fragmentation  and  nuclear 
condensation therefore, staining of cleaved-caspases and condensed nuclei are good indications 
of  apoptosis.    To  test  whether  HDAC2
C262A/C274A  impairs  proliferation  of  progenitor  cells, 
electroporated slices will be stained for the proliferation marker Ki-67.  Ki-67 is expressed during 
the active phases of the cell cycle, but absent in resting cells therefore, impaired proliferation will 
result in reduced Ki-67 staining (Scholzen and Gerdes 2000).  To further differentiate between 
defects in proliferation and radial migration, slices will be immuno-stained for the early neuronal 
markers HuD and βIII-tubulin.  Defective radial migration will result in an increased number of 
neuronal marker positive cells within the SVZ but not in the cortical plate.  However, if I observe 
that staining of HuD and βIII-tubulin is restricted to the cortical plate, I will conclude that radial 
migration is normal and that the phenotype is due to a defect in either proliferation or survival, or   100 
both.  Reduction of cells within the cortical plate following disruption of TrkB signalling is due 
to impaired proliferation, whereas radial migration remained normal (Bartkowska et al 2007).  
Since nitrosylation of HDAC2 is induced following TrkB signalling, a reduction in precursor 
cells expressing HDAC2
C262A/C274A within the cortical plate will probably be due to impaired 
proliferation. 
 
In summary, stimulation of cortical progenitor cells with BDNF increases intracellular Ca
2+ 
and leads to the activation of nNOS and nuclear accumulation of NO (Fig. 6.6).  A key nuclear 
target of NO is the chromatin-modifying enzyme, HDAC2 (Nott et al 2008).  S-nitrosylation of 
HDAC2 results in its dissociation from repressive complexes at gene promoters regulated by 
CREB (Fig. 6.6).  This leads to an increase of histone acetylation at specific promoter regions and 
initiation of gene transcription (Fig. 6.6) (Nott et al 2008).  Importantly, I have demonstrated that 
NO modulation of HDAC2 is necessary for dendritic growth in vitro (Nott et al 2008).  My 
preliminary  data  obtained  by  employing  an  ex  vivo  technique  suggest  that  nitrosylation  of 
HDAC2 may be important for radial migration of cortical precursors in vivo.  Two potential 
targets of NO-dependent inhibition of HDAC2 include the CREB-regulated genes Bdnf and Nos1.  
The expression pattern of both Bdnf and Nos1 in the developing cortex is very similar, with 
expression levels high in the IZ and cortical plate but absent from progenitor cells in the VZ.  
Furthermore, stimulation with BDNF induces transcription of Nos1 and Bdnf itself (Xiong et al 
1999; Cheng et al 2003).  A further potential candidate that may be regulated by nitrosylated 
HDAC2 is the pro-survival factor, Bcl2, which has been demonstrated to be induced upon NO-
dependent activation of CREB (Riccio et al 1999; Dhakshinamoorthy et al 2007).  Nitrosylation   101 
of HDAC2 during cortical development is likely to regulate a broad array of genes, which may 
provide further incite into the ability of cells to switch from proliferative to differentiated states.   102 
Figure 6.1 Formation of the neocortex into distinct neuronal layers.  At E11, the preplate 
(PP) is established by a postmitotic wave of neurons that has migrated along radial glia (vertical 
bars) from the ventricular zone (VZ) to the pial surface (PS).  A second wave of postmitotic 
neurons  migrates  through  the  intermediate  zone  (IZ)  at  E13,  splitting  apart  the  PP  into  the 
marginal zone (MZ) and the subplate (SP), thus creating the cortical plate (CP).  Subsequent 
waves of neurons exit the VZ through E14-E18, each wave passing previously established layers, 
forming the ‘inside-out’ six-layered neocortex. In adulthood the SP degenerates. (Taken from 
Gupta et al 2002). 
 
Figure 6.2 S-nitrosylation of HDAC2 regulates cortical dendritic growth.  Examples of 
cortical neurons transfected with HDAC2
WT, HDAC2
C262A/C274A, or EV control.  Cortical cultures 
were treated with KCl (50mM) or vehicle (Ctrl) for 48 hours before fixation.  Images were taken 
on an Axioplan 2 fluorescence microscope with a Plan Neofluar 25x/0.8 Corr objective lens and 
FS10 (GFP) filter set. Scale bar, 40 µm. 
 
Figure 6.3 Quantitative analysis of cortical neuron dendritic growth (Fig. 6.1).  Average 
dendritic  length  of  cortical  neurons  transfected  with  HDAC2
WT,  HDAC2
C262A/C274A  or  EV 
control.    Neuronal  cultures  were  treated  with  KCl  (50mM)  or  left  untreated  (Ctrl).    Each 
condition represents the analysis of 30 neurons per experiment (n=3); +/- SEM, *P<0.005. 
 
Figure 6.4 Ex vivo electroporation of cortical progenitors and organotypic slice culture 
allows the study of radial migration.  a. pCIG-green construct mixed with 0.5% Fast Green dye is 
injected  into  the  lateral  ventricles  of  an  intact  E14.5  mouse  embryo.    b.  The  intact  head  is   103 
immediately electroporated and the brain removed.  c. The brains are embedded in Low Melting 
Point (LMP) agarose and 250µm sections are sliced using a vibratome.  Slices are cultured on 
semi-permeable organotypic membranes for up to 10 days (Hand et al 2005). 
 
Figure 6.5 S-nitrosylation of HDAC2 influences radial migration of cortical progenitors.   
Ex vivo electroporation of mouse E14.5 embryonic cortical progenitors with either pCIG2:EGFP-
HDAC2
WT,  pCIG2:EGFP-HDAC2
C262A/C274A  or  pCIG2:EGFP  (empty  vector),  followed  by 
organotypic slice culture for 5 days in vitro.  Slices were immuno-labelled for GFP (green) and 
images captured using a Leica DMI6000 confocal microscope with HC PL APO 20x/0.7 Corr 
objective lens. 
 
Figure 6.5 HDAC2 nitrosylation mediates neurotrophin induced gene transcription.  In 
resting  neurons  repressive  complexes  recruit  HDAC2  to  gene  promoters,  which  result  in 
deacetylation  of  histones  and  gene  repression.    Neurotrophin  stimulation  of  cortical  neurons 
results in nuclear accumulation of NO and nitrosylation of nuclear proteins.  Nitrosylation of 
HDAC2 results in its dissociation from gene promoters, which correlates with an increase in 
histone acetylation and activation of gene transcription. 
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Chapter 7  Discussion 
 
The development of the nervous system is a complex process that involves the generation 
of a vast number of neuronal and glial cell types from a single uniform population of embryonic 
stem cells.  The birth of distinct neuronal populations is both spatially and temporally regulated.  
The  initial  cell  migration  process  precisely  defines  the  final  destination  of  neurons  and  is 
followed by the establishment of synaptic contacts within specific populations of target cells.  
Developmental  processes  are  heavily  reliant  on  the  availability  of  extracellular  cues  and  the 
responsiveness of progenitor cells to these cues.  We have demonstrated a novel mechanism 
whereby BDNF induces neuronal precursor cell differentiation and migration by regulating NO-
dependent HDAC2 function and gene activation (Nott et al 2008). 
 
I  demonstrated  that  BDNF-stimulation  of  embryonic  cortical  neurons  induces  NO 
accumulation within the nucleus (Nott et al 2008).  This accumulation of NO is  completely 
blocked  by  pre-treatment  of  cultures  with  the  nNOS  specific  inhibitor  NPA.    This  finding 
indicates  that  the  primary  source  of  NO  in  cortical  neurons  following  BDNF  stimulation  is 
endogenous nNOS.  Exposure of cortical cultures to BDNF increases intracellular accumulation 
of  NO  and  S-nitrosylation  of  nuclear  and  cytoplasmic  proteins  within  minutes.    The  rapid 
detection of NO and the requirement of Ca
2+ as a co-activator of nNOS suggest that a BDNF-
dependent  elevation  in  intracellular  Ca
2+  is  required.    TrkB  receptor  is  expressed  in  cortical 
progenitors throughout neuronal development and is maintained in fully differentiated pyramidal 
neurons.  TrkB signalling leads to activation of PLC-γ1, which catalyses the hydrolysis of PIP2 to 
produce the two intracellular messenger molecules IP3 and DAG.  Binding of IP3 to IP3 receptors   108 
located  on  the  endoplasmic  reticulum  leads  to  a  rapid  influx  of  intracellular  Ca
2+.    This  is 
probably the primary source of Ca
2+ in neurons following BDNF stimulation.  Activated IP3 
receptors  on  the  endoplasmic  reticulum  near  the  nuclear  envelope  will  produce  a  localised 
elevation of Ca
2+ in close proximity to the nucleus.  Perinuclear nNOS will subsequently be 
activated and contribute to nuclear accumulation of NO. 
 
An alternative source of intracellular Ca
2+ following neurotrophin stimulation is the TRPC 
ion channel.  These plasma-membrane store-operated channels are responsible for capacitance, a 
process that allows replenishment of depleted intracellular Ca
2+ stores following activation of IP3 
receptors.    TRPC  capacitance  significantly  contributes  to  BDNF-induced  increases  in 
intracellular Ca
2+ levels.  An established mechanism for TRPC ion channel gating in neurons is 
through BDNF-induced activation of PLC-γ1 (Li et al 1999; Clapham 2003; Amaral and Pozzo-
Miller 2007).  However, the contributing role of either IP3 receptors, DAG or Ca
2+ released from 
intracellular stores is still controversial (Kiselyov et al 1998; Hofmann et al 1999; Clapham et al 
2001).  Ca
2+ influx through activated TRPC channels may further contribute to elevated Ca
2+ 
levels following PLC-γ1 signalling.  Localisation of TRPC channels to the plasma membrane and 
IP3 receptors on the endoplasmic reticulum results in Ca
2+ influx from two spatially distinct 
sources.  This may allow the activation of specific subsets of NOS enzymes that are differentially 
localised within the cell, which may in turn initiate distinct signalling pathways. 
 
During  the  development  of  the  nervous  system,  BDNF-induced  activation  of  TRPC 
channels influences growth cone development in the mammalian brain (Li et al 1999; Li et al 
2005).  Interestingly, a recent report has linked BDNF-dependent neuronal survival with TRPC-  109 
induced activation of CREB (Jia et al 2007).  An attractive hypothesis is that an increase of 
intracellular Ca
2+ upon PLC-γ1 activation leads to nNOS activation and nuclear accumulation of 
NO.  It has previously been shown that NO-dependent CREB binding in cortical neurons occurs 
upon BDNF stimulation in a Ca
2+-dependent manner and is independent of both the Ras/ERK 
and PI-3 Kinase pathways (Riccio et al 2006).  Further pharmacological analysis will elucidate 
the role of PLC-γ1-induced activation of IP3R and TRPC channels for nNOS activation. 
 
I demonstrated that HDAC2 is nitrosylated on two specific cysteine residues (Nott et al 
2008).  However, thiol groups of cysteine residues can exist in a number of oxidative states, from 
S-nitrosylation (S-NO), sulphenic acid (S-OH), disulphide bond (S-S), sulphinic acid (SO2
–) to 
the irreversible sulphonic acid (SO
3-).  The ability of thiol groups to exist in successive oxidative 
states may add a further level of complexity to NO modulation of protein functions  (Fig. 7.1).  
The  oxidative  state  of  cysteine  residues  can  be  viewed  as  a  continuum  that  depends  on  the 
amount, origin, spatiotemporal distribution and order of the NO oxide species (NO/higher nitric 
oxides (NOx)/SNO).  Progression of protein modifications through oxidative states may allow a 
transition in cellular response from adaptive to oxidative stress and finally toxicity.  A striking 
example is provided by OxyR, a bacterial transcription factor with a cysteine residue (Cys199) 
that can stably exist in several oxidative states, either S-nitrosylated, S-hydroxylated (S-OH) or S-
glutathionylated (S-SG; mixed disulphide with glutathione) (Kim et al 2002).  These different 
modifications activate OxyR to various degrees, changing its affinity for DNA and its ability to 
bind in a cooperative or non-cooperative manner.  A similar mechanism may exist for HDAC2, 
whereby different oxidative states could change its tertiary and quaternary structure, influencing 
its affinity for specific repressive complexes.    110 
 
My findings indicate that physiological levels of NO following neurotrophin signalling, 
induces S-nitrosylation of HDAC2 and initiates transcription of genes necessary for neuronal 
development (Nott et al 2008).  It could be hypothesised that further increases in NO levels 
possibly associated with nitrosative stress, may result in sulphenic or sulphinic acid modifications 
of HDAC2 allowing the expression of genes that reduce intracellular reactive oxygen species 
(ROS).  Likewise, toxic levels of NO may generate irreversible sulphonic acid modifications of 
HDAC2  and  subsequently  activate  genes  associated  with  apoptosis.    The  presence  of  these 
modifications in a physiological intracellular environment will require the exposure of cells to 
various oxidative conditions followed by mass spectrometry analysis of HDAC2.  Interestingly, a 
3D  predicted  model  of  HDAC2  based  on  the  crystal  structure  of  HDAC8  estimates  that  the 
distance  between  Cys262  and  Cys274  is  15.6Å  and  that  one  residue  is  buried  within  a 
hydrophobic tunnel (Fig. 4.1) (Vannini et al 2004; Somoza et al 2004).  Similarly, in the reduced 
form  of  OxyR,  Cys199  and  Cys208  are  17Å  apart,  which  is  too  far  for  disulphide  bond 
formation.  A sulphenic acid intermediate forces Cys199 out of a hydrophobic pocket, permitting 
bond formation with Cys208 (Kim et al 2002).  This allows a more stable conformational change 
in OxyR and prolonged activation of the transcription factor.  A similar mechanism may apply to 
HDAC2,  with  the  formation  of  a  disulphide  bond  affecting  its  ability  to  oligomerise  with 
additional HDACs or with components of repressive complexes.  It should be noted however, 
that a stable S-nitrosylated form of HDAC2 must exist, because the use of ascorbic acid in the 
biotin-switch  assay  selectively  reduces  nitrosothiols  only,  while  cysteine  residues  in  other 
oxidative states remain unaffected (Forrester et al 2007). 
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I demonstrated that NO induces expression of multiple genes through S-nitrosylation of 
HDAC2 (Nott et al 2008).  These findings may provide a possible explanation for conflicting 
results  of  NO-dependent  regulation  of  transcription  factors.    For  example,  NO  has  opposing 
affects on NF-κB binding to DNA.  S-nitrosylation of NF-κB subunits reduces its affinity for 
DNA and stabilises its inhibitory cofactor IκB.  However, other studies have suggested that NO 
signalling induces the expression of genes regulated by NF-κB.  Similarly, NO negatively affects 
the binding of the AP1 transcription factor to DNA, although it also induces the expression of 
AP-1-regulated  genes,  including  Fos  itself.    It  is  possible  that  NO  initially  increases  gene 
transcription by modulating the acetylation state of histones through S-nitrosylation of HDAC2.  
This  event  is  followed  by  an  inhibitory-feedback  loop,  mediated  by  direct  nitrosylation  of 
transcription factors.  A further level of complexity is provided by the compartmentalisation of 
NO signalling.  For example, NF-κB is nitrosylated within the cytoplasm, whereas HDAC2 is 
modified within the nucleus.  Compartmentalisation of NO synthesis may be achieved in part by 
local increases of Ca
2+ and nNOS activation.  As previously discussed, activation of PLC-γ1 may 
lead to Ca
2+ influx, either through depletion of intracellular stores or activation of TRPC channels 
at  the  plasma  membrane,  providing  a  possible  mechanism  for  segregated  Ca
2+  entry  and 
signalling. 
 
Compartmentalised  NO  signalling  has  been  demonstrated  in  cardiomyocytes  though 
subcellular  segregation  of  two  NOS  isoforms,  which  results  in  discernable  isoform-specific 
cellular properties (Petroff et al 2001; Ashley et al 2002; Sears et al 2003).  Cortical neurons were 
thought to express a single nNOS isoform however, it has become apparent that nNOS exist as 
several splice variants.  There are three major splice variants of nNOS, the predominant wild-type   112 
variant nNOSα and two terminal truncated variants nNOSβ and nNOSγ.  The two truncated 
splice variants are missing an N-terminal PDZ domain that is present in nNOSα.  The PDZ 
domain  is  responsible  for  targeting  nNOSα  to  the  postsynaptic  density  proteins  PSD93  and 
PSD95 therefore, nNOSβ and nNOSγ are presumed to be soluble.  nNOSγ is missing a further 
three structural motifs important for its dimerization, resulting in a catalytic activity lower than 
the other two variants.  Differences in expression, subcellular localisation and activity of nNOS 
N-terminal splice variants would allow the compartmentalisation of NO signalling between the 
cytoplasm and the nucleus.  This may result in NO-dependent regulation of transcription factors, 
such as NF-κB, which normally reside in the cytoplasm and then shuttle into the nucleus upon 
activation. 
 
Preliminary ex vivo data suggest that S-nitrosylation of HDAC2 is necessary for the proper 
radial migration of cortical progenitors.  Previous data have implicated both BDNF and NO 
signalling in regulating the differentiation and migration of neuronal precursors (Barnabe-Heider 
and Miller 2003; Ito et al 2003; Cheng et al 2003; Ciani et al 2004).  The transition of progenitor 
cells  to  pyramidal  neurons  is  determined  by  the  outcome  of  two  conflicting  processes, 
proliferation and differentiation.  bHLH transcription factors are the foremost regulators of both 
these  processes:  Id  and  Hes  families  maintain  proliferation,  whereas  the  neurogenin  family 
promotes neuronal differentiation and exit from the cell cycle.  Ngn2, a pro-neural bHLH factor 
expressed in the VZ, is a key regulator of cell  cycle arrest and neurogenesis during cortical 
development  (Hevner  2006).    The  temporal  and  spatial  expression  of  Ngn2  during  cortical 
development makes it a potential target of NO-dependent HDAC2 regulation (Fode et al 2000; 
Murciano et al 2002; Miyata et al 2004; Schuurmans et al 2004).  Transient expression of Ngn2   113 
triggers a second wave of sustained bHLH expression, including NeuroD, NeuroD2 and Nex.  
These factors alone are sufficient for promoting cell cycle arrest and neuronal differentiation.  
Therefore,  my  preliminary  observations  that  electroporated  cortical  slices  have  reduced 
HDAC2
C262A/C274A  positive  neurons  within  the  cortical  plate  may  reflect  a  disruption  in 
neurogenesis.  This finding is supported by a recent study that shows impaired neurogenesis of 
cortical progenitors upon inhibition of BDNF signalling, using an in utero electroporation system 
(Bratkowska et al 2007). 
 
The NeuroD/Nex factors are both necessary and sufficient for cell cycle arrest and neuronal 
differentiation of cortical progenitors.  Interestingly, the NeuroD, NeuroD2 and Nex transcription 
factors are highly expressed in the IZ and cortical plate, which mirrors cortical expression of 
nNOS (Bredt and Snyder 1994; Lee et al 2000).  Since these transcription factors also play a 
prominent  role  in  cell  cycle  arrest  and  differentiation,  S-nitrosylation  of  HDAC2  may  first 
regulate expression of NeuroD/Nex factors through inhibiting Ngn2 binding to DNA, and later 
also regulate DNA-binding of NeuroD/Nex factors.  Recent studies have suggested that Ngn2 
may modulate additional  aspects of  cortical development distinct from its proneural activity.  
Ngn2 null mice exhibit defects in cortical radial migration, directly implicating Ngn2 activation 
in pyramidal migration and unipolar dendritic morphology (Hand et al 2005; Heng et al 2008).  
The small GTP-binding protein Rnd2 is induced in progenitor cells by Ngn2 and its expression is 
sufficient  to  rescue  migration  defects  in  Ngn2-mutant  cells  (Heng  et  al  2008).    Neurons 
expressing HDAC2
C262A/C274A may have reduced Rnd2 expression, which subsequently impairs 
cortical  radial  migration.  Therefore,  HDAC2
C262A/C274A–mediated  repression  of  bHLH  target 
genes may have a combined affect on neurogenesis and radial migration.   114 
 
Cortical development requires the coupling of multiple cellular pathways, many of which 
appear to be influenced by NO signalling.  The cyclin-dependent kinase inhibitor, p27
Kip1, is 
capable of binding cyclin/cyclin-dependent kinase complexes to initiate cell cycle withdrawal.  
p27
Kip1 is highly expressed in the IZ and cortical plate, as cortical precursors stop proliferating 
and differentiate to form pyramidal neurons.  An exciting study has recently demonstrated that 
p27
Kip1 is a modular protein capable of independently regulating multiple aspects of neurogenesis 
(Nguyen  2006).    The  N-terminal  region  of  p27
Kip1  stabilises  Ngn2  thus  promoting  neuronal 
differentiation whereas the C-terminal region of p27
Kip1 inhibits RhoA activity thus promoting 
radial  migration  of  cortical  neurons  (Nguyen  2006).    In  fibroblasts,  levels  of  p27
kip1  are 
significantly increased upon HDAC inhibition, and this event plays a critical role in determining 
cell cycle arrest (Chen and Faller 2005).  The spatial expression of p27
Kip1 and its ability to 
modulate multiple aspects of neurogenesis makes it a potential target of S-nitrosylated HDAC2 
during cortical development. 
 
HDACs themselves have recently been implicated as possible regulators of corticogenesis 
(Humphrey et al 2008; Shaked et al 2008).  Overexpression of a dominant-negative (dn) HDAC2 
construct in neural stem cells led to a two-fold increase of the astrocyte marker glial fibrillary 
acidic protein (GFAP), with no discernable difference of other neuronal markers (Humphrey et al 
2008).  GFAP is expressed in radial glial cells and astrocytes, leading the authors to suggest that 
HDAC2 may repress a transition from an ‘early’ to ‘late’ stem cell state, or possibly repress 
mitotic  arrest  of  newly  formed  radial  glial  cells  (Humphrey  et  al  2008).    An  advantage  of 
expressing dnHDAC2 over a knockdown approach is that the protein is still present and capable   115 
of forming repressive complexes.  Therefore, any phenotype observed is likely to be dependent 
on  HDAC  activity.    It  has  previously  been  demonstrated  that  the  corepressor  complex, 
HDAC2/CoREST, is required for REST repression in neurons (Ballas et al 2001).  An intriguing 
possibility is that a loss of HDAC2 activity is required for the generation of astrocytes, while the 
presence of an inactive form of HDAC2 is still capable of recruiting additional co-repressors to 
the REST complex.  In this model, HDAC2 function is dependent on its ability to act as a 
scaffold protein for the recruitment of co-repressors to gene promoters and is not dependent on its 
deacetylase activity. 
 
HDAC inhibition promotes neurogenesis in the cerebral cortex in a Bone Morphogenetic 
Protein-2 (BMP2)-dependent manner (Shaked et al 2008).  TSA inhibition of HDACs induces 
BMP2 expression with a corresponding increase of cells that exit the ventricular zone (Shaked et 
al 2008).  BMP expression is first detected in the telencephalon at E10.5, and is maintained 
throughout the period of cortical neurogenesis (Dewulf et al 1995).  Application of BMP2 to 
radial glial cultures increases the number of cells expressing neuronal-specific markers (Li et al 
2007), while retroviral transfection of radial-glia with a dominant-negative BMP type I receptor 
blocks neurite elaboration and cell migration out of the VZ (Li et al 1998).  BMP signalling is 
further  complicated  by  the  observation  that  different  concentrations  of  BMP2  have  opposite 
effects on radial glial responses (Mabie et al 1999).  Low BMP2 levels (1-10ng/ml) promote 
neuronal  differentiation,  whereas  higher  levels  (100ng/ml)  inhibit  proliferation  and  promote 
apoptosis (Mabie et al 1999).  BMP2 gradients appear to have an important function in cortical 
development.  BMP signalling is dependent on expression of the BMP ligand, receptors, as well 
as BMP inhibitors such as noggin, any of which may be induced within the developing cortex   116 
following nitrosylation of HDAC2.  According with these observations, I found that ex vivo 
electroporation of HDAC2
C262A/C274A into progenitor cells of the VZ impairs radial migration of 
neuronal precursors during development.  This demonstrates that nitrosylation of HDAC2 has a 
dramatic affect on processes crucial for cortical development. 
 
Previous  observations  indicate  that  histone  acetylation  plays  an  important  role  in  the 
pathogenesis of several neurodegenerative disorders, including Huntington’s, Parkinson’s and 
Alzheimer’s disease.  The majority of studies that investigate HDACs as a therapeutic tool for 
neurodegenerative  disorders  have  been  focused  on  the  treatment  of  polyglutamine  disorders 
(Butler and Bates 2006).  Disruption of neuronal function in polyglutamine disorders, such as 
Huntington’s  disease  (HD),  is  associated  with  the  formation  of  expanded-polyglutamine 
aggregates that sequester intracellular proteins important for multiple signalling pathways.  It has 
now  become  apparent  that  transcriptional  cofactors  are  included  within  these  aggregates, 
perturbing histone modification and gene expression (Hughes 2002).  Transcription factors and 
co-activators, including p53, CBP, P/CAF and TATA-binding proteins are sequestered within 
mutant  Huntingtin  (HTT)  aggregates,  resulting  in  global  hypoacetylation  of  chromatin 
(McCampbell et al 2000; Steffan et al 2000; Nucifora et al 2001; Dunah et al 2002; van Roon-
Mom  et  al  2002).    Additionally,  HDAC2  association  to  neuronal  gene  promoters  further 
exacerbates the transcriptional dysregulation observed in HD (Zuccato et al 2001) (Zuccato et al 
2003).  In non-neuronal cells, REST associates with co-repressors Sin3A, HDAC1 and HDAC2 
and is recruited to neuron restrictive silencing elements (NRSE), resulting in hypoacetylation and 
silencing  of  neuronal  genes.    In  healthy  neurons,  wild-type  HTT  binds  REST  within  the 
cytoplasm, preventing its association and targeting of repressive complexes to neuronal genes   117 
(Zuccato  et  al  2003).    However,  mutant  HTT  is  not  capable  of  binding  REST,  resulting  in 
downregulation of neuronal genes, such as BDNF (Zuccato et al 2001).  HDAC inhibitors are 
therefore being considered as novel and promising therapeutic agents for HD. 
 
The deacetylase activity of HDACs involves the removal of an acetyl group through a 
charge-relay system that consists of a histidine residue and two aspartate residues.  The charge-
relay system relies on a Zn
2+ ion bound to the bottom of the active site pocket (Finnin et al 1999; 
Vannini et al 2004; Somoza et al 2004).  The majority of HDAC inhibitors function by binding to 
the zinc ion and disrupting the charge-relay system.  Residues essential for zinc binding and the 
charge relay system are highly conserved between class I and II HDACs, which greatly hinders 
the generation of HDAC-specific inhibitors.  Another consideration in using HDAC inhibitors as 
a therapeutic strategy is that a significant number of HDAC substrates are non-histone proteins, 
whose regulation by HDACs may still be beneficial. 
 
S-nitrosylation  regulates  HDAC2  localisation  at  gene  promoters  independent  of  its 
deacetylase activity and provides a novel approach for the design of HDAC inhibitors (Nott et al 
2008).  The nitrosylated cysteines of HDAC2 are conserved only among class I HDACs, which 
allows for the design of class-specific drugs.  Furthermore, the location of both cysteine residues 
outside  the  highly  conserved  active  site  will  permit  the  development  of  individual  HDAC-
specific inhibitors.  A major advantage of targeting nitrosylated residues outside the active site is 
that HDAC function at specific gene promoters will be affected, without inhibiting global HDAC 
activity.    Hypoacetylation  observed  in  neurodegenerative  diseases  is  due  to  a  loss  of  HAT 
activity, while the total HDAC protein level remains comparably similar to healthy neurons (Saha   118 
and Pahan 2006).  Therefore, inhibition of HDAC localisation at gene promoters will reduce the 
acetylation  level  of  chromatin-associated  substrates,  while  non-histone  targets  will  remain 
unaffected. 
 
HDACs play an important role in regulating cell proliferation, differentiation and apoptosis.  
Therefore, it is not surprising that they have been a major focus for cancer therapeutics for the 
past 10 years (Ginsburg et al 1973; Altenburg et al 1976; Boffa et al 1978).  Many cancer types 
exhibit enhanced expression of HDACs, with a corresponding decrease of antiproliferative genes, 
such as the cyclin-dependent kinase inhibitor p21 (Lagger et al 2002; Glozak and Seto 2007).  
HDAC2 is highly expressed in gastric carcinomas, colorectal carcinomas, cervical dysplasias and 
endometrial stromal sarcomas, along with reduced p21 expression (Huang et al 2005; Song et al 
2005; Hrzenjak et al 2006).  HDAC2 expression in intestinal mucosas is elevated by the loss of 
function  of  the  tumour  suppressor  adenomatosis  polyposis  coli  (APC)  (Zhu  et  al  2004).  
Expression levels of p21 and other proapoptotic genes, such as Bax, can be restored in APC null 
mice by treatment with HDAC inhibitors (Myzak et al 2006).  This correlates with increased 
acetylation of gene promoters and increased apoptosis.  However, certain sporadic colorectal 
carcinomas  express  a  mutant  truncated  form  of  HDAC2  that  is  resistant  to  current  inhibitor 
treatments (Ropero et al 2006).  Designing drugs that disrupt DNA HDAC2 interaction instead of 
targeting the active site may provide an alternative treatment strategy against mutant variants of 
HDAC2 that no longer respond to current inhibitors. 
 
Our findings have implications that reach beyond the regulation of cortical development, 
with possible therapeutic implications for both neurodegenerative disorders and cancer.  NO and   119 
chromatin  remodelling  have  been  associated  with  various  learning  and  memory  paradigms 
(Susswein et al 2004).  Exposure of mice to a novel enriched environment induces transcription 
of genes that are impaired in nNOS null mice (Riccio et al 2006).  Notably, inhibition of HDAC 
activity  in  a  neurodegenerative  mouse  model  profoundly  improves  learning  capabilities  and 
retrieval of previously lost memory (Fischer et al 2007).  HDAC inhibitors are already considered 
as a possible therapeutic strategy for improving memory loss associated with neurodegenerative 
disorders.  The regulation of HDACs through NO signalling has unveiled an  alternative and 
exciting avenue for the design of alternative therapeutic approaches. 
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Chapter 8  Experimental Procedure 
 
8.1 Reagents 
 
Unless otherwise stated, all biochemical reagents described were purchased from Sigma 
(UK) and all tissue culture reagents from Gibco (Invitrogen, UK).  SNOC was always prepared 
fresh and used immediately by combining 220µl 220mM cysteine, 220µl 220mM sodium nitrate 
and 25µl 4M HCl (Mallis et al 2001).  SNOC was incubate in the dark at room temperature for 10 
minutes  and  then  the  reaction  was  stopped  with  25µl  4M  NaOH.    SNOC  has  an  extinction 
coefficient of 900M
-1A.cm
-1 and absorption at 338nm. 
 
8.2 Cell Cultures 
 
Primary cultures were performed on E17.5 rat and E16.5 mouse embryos.  Dissociated 
cultures were plated on Nunc plastic (Invitrogen, UK) coated with 1mg/ml PDL (Sigma, UK) and 
1mg/ml Laminin (BD Bioscience, NJ) diluted 1:50 and 1:500 respectively.  Brains were removed 
from the head, the meninges were separated and the cortices were isolated and stored in ice-cold 
HBSS medium (supplemented with 2.5mM Hepes pH 7.4, 35mM glucose, 1mM CaCl2, 1mM 
MgSO4, 4mM NaHCO3).  After completion of the dissection the HBSS medium was removed 
and an enzyme solution was added which contained 400U papain (Worthington, NJ) diluted in 
dissociation medium (81.75mM Na2SO4, 30mM K2SO4, 5.8mM MgCl2, 250nM CaCl2, 1mM 
Hepes pH 7.4, 20mM glucose, 0.001% phenol red).  The cortices were digested at 37
oC for 25 
minutes, followed by four washes with dissociation medium to remove the papain.  The cortices   121 
were pipette dissociated in MEM medium supplemented with 10% foetal bovine serum (FBS), 
5% horse serum (HS) and 1mM glutamine and the cells were passed through a strainer.  Mouse 
cultures  were  dissociated  in  Neurobasal  medium  supplemented  with  1X  B27  and  1mM 
glutamine.  Cultures were plated at 15M cells per 10cm
2 plate for biochemistry, 2.5M per 6-well 
for the dual luciferase assay, 0.2M per 4-well for DAF imaging, or 0.3M per 4-well for the 
morphology experiments. Plates were incubated at 37
oC, 5% CO2 and starved overnight prior to 
experiments in 3% FBS serum and 50µM AP5. 
 
HEK239T cells and PC12 cells were maintained in DMEM supplemented with 10% FBS, 
and  10%  FBS  plus  5%  HS,  respectively.    Before  experiments,  PC12  cells  were  starved  in 
medium containing 0.5% HS overnight. 
 
8.3 nNOS mouse line 
 
nNOS null mice (Huang et al 1993) or wild-type controls (C57 Black/6) were interbred to 
produce  nNOS  null  and  wild-type  litters,  respectively.    Embryos  were  taken  at  E16.5  for 
dissociated cortical culture. 
 
8.4 Constructs and Transfections 
 
The  pME18S-HDAC2  (FLAG-tagged)  construct  was  kindly  provided  by  Dr  E  Seto 
(Laherty et al 1997).  Cysteine mutants were obtained using the Quickchange® II site-directed 
mutagenesis  kit  (Stratagene,  UK)  according  to  the  manufacturers  instructions.    HDAC2   122 
truncations  were  cloned  into  a  pCMV-Myc  plasmid  (Clontech)  using  primers  that  contained 
5’SalI  and  3’NotI  restriction  sites.    HDAC2  was  cloned  into  a  modified  pCIG2-IRES-eGFP 
construct containing an expression cassette under the control of a CMV enhancer and a chicken 
β-actin promoter using primers that contained 5’EcoRI and 3’XmaI restriction sites (Hand et al 
2005). 
 
All transfections were performed using Lipofectamine® 2000  (Invitrogen, UK) as follows, 
unless  otherwise  stated.    The  plating  medium  was  removed  and  replaced  by  OptiMEM  that 
contained Lipofectamine 2000 (diluted 1:65) plus 1.5µg/ml of DNA.  Medium containing the 
transfection reagent and DNA was incubated at room temperature for 20 minutes before applying 
to the cells.  Transfections were left at 37
oC, 10% for 4 hours before replacing the transfection 
medium by the original serum-containing medium.  
 
8.5 DAF Imaging 
 
Imaging was performed on E17 rat cortical neurons at 4 days in  vitro.  Neurons were 
starved for 16 hours in medium that contained 3% serum and AP5 (50µM) prior to experiments.  
Neurons were loaded with DAF-FM DA dye by replacing medium with DMEM (containing no 
phenol) plus 1mM glutamine, 50µM APV and 10µM DAF at 37
oC, 5% CO2 for 30 minutes.  
Cells  were  washed  three  times  in  DMEM  medium  and  incubated  at  37
oC,  5%  CO2  for  15 
minutes.  This allowed deacetylation of DAF-FM DA, which produced the cell impermeable and 
weakly fluorescent DAF-FM.  Neurons were treated with BDNF (100ng/ml), NPA (300µM), 
NPA plus BDNF or vehicle (Ctrl) for 30 minutes.  NO released within neurons reacted with   123 
DAF-FM to produce a fluorescent benzotriazole derivative, with excitation/emission maxima of 
495/515nm.    After  treatment,  neurons  were  left  in  medium  which  contained  2.67ng/ml  Cell 
Tracker Red CMTPX (Invitrogen, UK) for 30 minutes to allow visualisation of cell morphology.  
Cells were washed in PBS and fixed in 4% PFA for 15 minutes before mounting. Imaging was 
performed on a Leica DM 2500 confocal microscope using an ACS APO 40x/1.15 oil objective 
lens within 48 hours of fixation. 
 
8.6 Biotin-switch Assay 
 
The  following  is  based  on  a  previously  described  protocol  with  minor  modifications 
(Jaffrey and Snyder 2001; Forrester et al 2007).  All the following steps were performed in the 
dark.  Cells were washed in ice cold PBS and lysed in HEN buffer [250mM HEPES, 1mM 
EDTA, and 100mM neocuproine).  Nuclei were disrupted using a hand-held homogeniser for 15 
seconds.  Cell debris was pelleted at 750xg for 10 minutes and the resultant lysate adjusted to 
0.4% CHAPS.  Reduced cysteine thiol groups were blocked using 3 volumes of blocking buffer 
(HEN buffer plus 2.5% SDS and 200mM Methyl methanethiosulphonate) at 50
oC for 1 hour.  
The blocking buffer was removed by acetone precipitation.  Two volumes of -20
oC acetone was 
added to the samples and left at -20
oC for 20 minutes to precipitate the protein.  The samples 
were spun at 2000xg for 10 minutes, washed with 1ml -20
oC acetone and spun for a second time.  
Precipitated  protein  was  resuspended  in  100µl  HENS  buffer  (HEN  buffer  plus  1%  SDS).  
Nitrosylated cysteine residues were reduced to free thiol groups using fresh 100mM ascorbic 
acid.  The newly exposed cysteine thiol groups were labelled using 1mM biotin-HPDP at room 
temperature for 1 hour.  Proteins were then separated by SDS-PAGE electrophoresis and detected   124 
by western blotting using a streptavidin-HRP antibody.   Alternatively, biotinylated protein were 
first isolated by immunoprecipitation.  Excess biotin-HPDP was removed by a second acetone 
precipitation  and  proteins  were  resuspended  in  100µl  HENS  buffer.    Two  volumes  of 
neutralization buffer (20mM HEPES, 100mM NaCl, 1mM EDTA, 100mM β–mercaptoethanol 
[β–ME]) were added with 50µl streptavidin-agarose beads and rotated at room temperature for 1 
hour.  Beads were washed five times  with 1ml high salt neutralisation buffer (neutralisation 
buffer plus 600mM NaCl).  Biotinylated proteins were eluted using 50µl Elution buffer (20mM 
HEPES, 100mM NaCl, 1mM EDTA, 100mM β–ME) and boiled in SDS-loading buffer for 10 
minutes at 96
oC. 
 
8.7 Histone deacetylase Activity Assay 
 
The  HDAC  activity  assay  required  the  presence  of  HDACs  to  deacetylate  the  non-
fluorogenic  peptide,  BOC-(acetyl)lys-AMC  (Bachem,  UK),  which  could  subsequently  be 
digested by trypsin to produce a fluorescent moiety (Wegener et al 2003).  Cells (60mm plates) 
were washed with PBS and lysed in 500µl Low Salt IP Buffer (50mM Tris-HCl pH8.0, 150mM 
NaCl, 5mM EDTA, 0.5% NP40).  Cells were homogenised for 10 seconds and debris spun down 
at 20,000xg for 15 seconds.  HDAC2 was immunoprecipitated using 5µg antibody (anti-FLAG-
M2 mouse monoclonal, Sigma; anti-HDAC2 rabbit polyclonal, Santa Cruz Biotechnology) at 4
oC 
for 2 hours.  Protein A sepharose beads (50µl) were added and rotated for 1 hour at 4
oC.  The 
beads were washed and centrifuged three times using Low Salt IP Buffer at 6100xg.  The beads 
were washed twice in HDAC buffer (25mM Tris-HCl pH8.0, 137mM NaCl, 2.7mM KCl, 1mM 
MgCl2) to remove NP40 detergent.  After the final wash, 60ul HDAC buffer containing 100µM   125 
HDAC peptide was added and agitated vigorously at 37
oC for 1 hour.  The HDAC assay was 
stopped using 1µM TSA (Tocris Bioscience, UK) and the peptide digested using 5mg/ml trypsin 
at  room  temperature  for  15  minutes.    The  excitation/emission  maxima  was  measured  at 
355/460nm on a SpectraMax Gemini plate reader (Molecular Devices, USA). 
 
8.8 Chromatin ImmunoPrecipitation 
 
Approximately 3.5x10
6 cells were used per ChIP.  Cells were treated and then the medium 
was  replaced  with  PBS  containing  1%  formaldehyde.    Cells  were  rinsed  twice  in  PBS,  and 
harvested in collection buffer (100mM Tris-HCl pH9.4 and 1mM dithiothreitol).  Cells were 
pelleted, washed in PBS and the pellet resuspended in lysis buffer (0.1% SDS, 0.5% Triton X-
100, 20mM Tris-HCl, pH8.1 and 150mM NaCl).  Samples were sonicated on ice with a 20 sec 
pulse followed by a 10 sec interpulse interval, repeated six times.  Cell debris was removed by 
centrifugation  and  the  supernatant  pre-cleared  using  Protein  A  Sepharose  beads  (Amersham 
Biosciences) for 1 h at 4
oC.  Beads were pelleted by centrifugation and the supernatant was 
retained  for  immunoprecipitation.    A  fraction  of  the  supernatant  was  collected  for  pre-
immunoprecipitation total input.  The volume of each sample was adjusted to 500µl using lysis 
buffer,  and  immunoprecipitation  was  performed  overnight  at  4
oC  using  5-10µg  of  rabbit 
polyclonal antibody.  The following antibodies were used: anti-HDAC2 (Santa Cruz), anti-acetyl 
Histone H3 K9/K14 (Upstate), anti-acetyl Histone H4 (Upstate), control IgG (Santa Cruz) and 
anti-Flag M2 monoclonal antibody (Sigma).  Immune complexes were precipitated by incubating 
with Protein A Sepharose beads for 1 h at 4
oC.  Beads were collected and subjected to a series of 
seven sequential washes at 4
oC as follows: 1x lysis buffer 10 min, 1x lysis buffer 5 min, 1x wash   126 
buffer (0.1% SDS, 0.5% Triton X-100, 2mM EDTA pH 8.0, 20mM Tris-HCl pH8.1, 150mM 
NaCl) 10 min, 1x wash buffer 5 min, 1x LiCl buffer (0.25M LiCl, 1% NP-40, 1% deoxycholate, 
1mM EDTA pH 8.0, 10mM Tris-HCl pH 8.1) 5 min, 1x TE buffer (10mM Tris-base pH 8.1, 
1mM EDTA  pH8.0) 30 min, 1x TE buffer 5 min.  Immune complexes were eluted from beads by 
vortexing in elution buffer (1% SDS and 0.1M NaHCO3 pH 8.0).  DNA-protein cross-linking 
was reversed by adding NaCl at a final concentration of 0.33M and incubated at 65
oC overnight.  
DNA fragments were purified using the QIAquick PCR purification kit (Qiagen).  For PCR, 
specific sets of primers were designed that flank the CRE element within the upstream regulatory 
regions  of  Fos,  Egr1,  Vgf  and  Nos1.    PCR  conditions  and  cycle  numbers  were  determined 
empirically for the different templates and primer sets. Primers amplified fragments ranging in 
size from 200-400bp. 
 
8.9 Quantitative real time PCR 
 
PCR reactions (25µl) contained 12.5µl of PCR Sybr Green mix (NEB) and 0.3µM primers. 
All reactions were performed in duplicate with an Opticon 2 system (MJ Research) and each 
experiment included a standard curve, a preimmune control and NO template control.  Standard 
templates consisted of gel-purified PCR products of the Fos, Egr1, Vgf and Nos1 amplicons of 
known concentration, and each standard curve consisted of seven serial dilutions of the template.  
At the end of the 46 cycles of amplification, a dissociation curve was performed in which Sybr 
Green was measured at 1
oC intervals between 50
oC and 100
oC.  Melting templates for Fos, Egr1, 
Vgf, and Nos1 were 83
oC, 88
oC, 85
oC, respectively.  Results were normalised using total input 
DNA and expressed as fold changes over the unstimulated control.   127 
 
8.10 Dual Luciferase Reporter Assay 
 
E17 rat cortical neurons were cultured on 6-well plates at 250,000 cells/well and transfected 
after four days in vitro.  Neurons were transfected with 2µg HDAC2 vector, 2µg c-fos-luciferase 
(firefly) and 1µg TK-luciferase (Renilla) in 1ml media containing 10µl lipofectamine (Invitrogen, 
UK).    Forty-eight  hours  after  transfection,  cells  were  treated  with  BDNF  (75ng/µl),  SNOC 
(200µM), NPA (300µM) or NPA plus BDNF for 6 hours. Plates were then washed twice with ice 
cold PBS and processed using the Dual Luciferase® Reporter Assay System (Promega, UK) 
according to the manufacturers recommended protocol. 
 
8.11 Dendritic Growth Analysis 
 
E17 rat cortical cultures were plated on 4-well plates containing No.1.5 13mm coverslips at 
300,000 cells/well.  Transfection was performed 5 hours post-plating, allowing time for neurons 
to attach but before the majority had established projections.  Plates were left in the transfection 
medium for 4 hours before performing a complete medium change.  Neurons were either treated 
with KCl2 (50mM, 30 mins) or left unstimulated.  Coverslips were fixed for 48 hours post-
transfection  using  4%  PFA.    Cells  were  visualised  using  an  Axioplan2  microscope  (Zeiss,  
Germany) with a ‘Plan-Neofluar’ 25x/0,80|mm Corr. DIC Objective (Zeiss) and FS10 (GFP) 
filter  set  (Zeiss).    Dendritic  growth  was  analysesd  using  OpenLab  5.5  (Improvision.com)  as 
previously described (Redmond et al 2000; Redmond et al 2002). 
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8.12 Ex Vivo Electroporation 
 
The following ex vivo protocol was developed by Dr Franck Polleux (Polleux and Ghosh 
2002). Electroporation was performed using E14.5 mouse embryos.  pCIG2-HDAC2-IRES-eGFP 
constructs (1µg/ml) were microinjected into the lateral ventricles in 0.05% Fast Green Dye using 
a PLI-100 Pico-injector (Harvard Apparatus, MA) set at pulse length 2ms, PINJECT 0.3, PBALANCE 
0.1.    Mouse  brains  were  electroporated  using  ECM  830  Electro-Square-Porator  (Harvard 
Apparatus, MA) with gold plated Genepaddles (Fisher scientific, UK) using three unipolar pulses 
set to 30V (100ms interval and pulse length).  Electroporated brains were immediately transferred 
to ice cold cHBSS medium (1x HBSS, 2.5M Hepes pH7.4, 30mM D-glucose, 1mM CaCl2, 1mM 
MgSO4  and  4mM  NaHCO3).    Electroporated  brains  were  embedded  in  7%  LMP  agarose 
dissolved in cHBSS medium using Tissue Embedding Molds (Polysciences, PA).  Brain slices 
were obtained using a Vibratome 1000 Plus (Harvard Apparatus, MA) set to 250µM.  Slices were 
cultured on semi-permeable organotypic membranes in slice culture medium (70% MEM, 30% 
cHBSS, 20mM D-glucose, 1mM L-glutamine, 100units/ml penicillin and 0.1mg/ml streptomycin) 
at 37
oC, 5% CO2 for up to 5 days in vitro.  Slices were fixed in 4% PFA overnight, and immuno-
stained using Nestin (Santa Cruz) and GFP (Abcam) antibodies.  Slices were visualised on a 
Leica DMI 6000 confocal microscope using a HC PL APO 20x/0.7 Corr. objective lens. 
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8.13 Statistical Analysis 
 
Statistical analysis was performed using Prism 4 for Mac software.  Data for the DAF 
experiment  and  HDAC2  Activity  Assay  (Fig  4.1)  were  analysed  using  one-way  ANOVA 
followed by comparison using unpaired T-test. All other quantitative data was analysed using 
two-way ANOVA.   130 
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